{"parse":{"title":"Prostate cancer screening","pageid":3346770,"revid":860314289,"text":{"*":"<div class=\"mw-parser-output\"><table class=\"infobox\" style=\"width:22em\"><tbody><tr><th colspan=\"2\" style=\"text-align:center;font-size:125%;font-weight:bold;background-color: lightblue\">Prostate cancer screening</th></tr><tr><td colspan=\"2\" style=\"text-align:center\">\n<i><a href=\"/wiki/Medical_diagnosis\" title=\"Medical diagnosis\">Medical diagnostics</a></i></td></tr><tr><th scope=\"row\">Purpose</th><td>\ndetect undiagnosed <a href=\"/wiki/Prostate_cancer\" title=\"Prostate cancer\">prostate cancer</a>(where symptom onset has not begun)</td></tr></tbody></table>\n<p><b>Prostate cancer screening</b> is the <a href=\"/wiki/Screening_(medicine)\" title=\"Screening (medicine)\">screening</a> process used to detect undiagnosed <a href=\"/wiki/Prostate_cancer\" title=\"Prostate cancer\">prostate cancer</a> in those without <a href=\"/wiki/Medical_sign\" title=\"Medical sign\">signs</a> or <a href=\"/wiki/Symptoms\" class=\"mw-redirect\" title=\"Symptoms\">symptoms</a>.<sup id=\"cite_ref-PDQ2018_1-0\" class=\"reference\"><a href=\"#cite_note-PDQ2018-1\">&#91;1&#93;</a></sup><sup id=\"cite_ref-NCI_2-0\" class=\"reference\"><a href=\"#cite_note-NCI-2\">&#91;2&#93;</a></sup> When abnormal prostate tissue or cancer is found early, it may be easier to treat and cure, but it is unclear if early detection reduces mortality rates.<sup id=\"cite_ref-NCI_2-1\" class=\"reference\"><a href=\"#cite_note-NCI-2\">&#91;2&#93;</a></sup>\n</p><p>Screening precedes a diagnosis and subsequent treatment. The <a href=\"/wiki/Digital_rectal_examination\" class=\"mw-redirect\" title=\"Digital rectal examination\">digital rectal examination</a> (DRE) is one screening tool during which the prostate is assessed manually through the wall of the rectum. The second screening tool is the measurement of <a href=\"/wiki/Prostate-specific_antigen\" title=\"Prostate-specific antigen\">prostate-specific antigen</a> (PSA) in the <a href=\"/wiki/Blood\" title=\"Blood\">blood</a>. The evidence remains insufficient to determine whether screening with prostate-specific antigen (PSA) or digital rectal exam (DRE) reduces mortality from prostate cancer.<sup id=\"cite_ref-PDQ2018_1-1\" class=\"reference\"><a href=\"#cite_note-PDQ2018-1\">&#91;1&#93;</a></sup> A 2013 <a href=\"/wiki/Cochrane_(organisation)\" title=\"Cochrane (organisation)\">Cochrane</a> review concluded PSA screening results in \"no statistically significant difference in prostate cancer-specific mortality...\" The American studies were determined to have a high bias. European studies included in this review were of low bias and one reported \"a significant reduction in prostate cancer-specific mortality.\" PSA screening with DRE was not assessed in this review. DRE was not assessed separately.<sup id=\"cite_ref-:7_3-0\" class=\"reference\"><a href=\"#cite_note-:7-3\">&#91;3&#93;</a></sup> \n</p><p>Guidelines generally recommend that the decisions whether or not to screen be based on <a href=\"/wiki/Shared_decision-making\" class=\"mw-redirect\" title=\"Shared decision-making\">shared decision-making</a>.<sup id=\"cite_ref-4\" class=\"reference\"><a href=\"#cite_note-4\">&#91;4&#93;</a></sup> This involves men being informed of the risks and benefits of screening.<sup id=\"cite_ref-5\" class=\"reference\"><a href=\"#cite_note-5\">&#91;5&#93;</a></sup><sup id=\"cite_ref-6\" class=\"reference\"><a href=\"#cite_note-6\">&#91;6&#93;</a></sup> The <a href=\"/wiki/American_Society_of_Clinical_Oncology\" title=\"American Society of Clinical Oncology\">American Society of Clinical Oncology</a> recommends screening be discouraged in those who are expected to live less than ten years, while in those with a life expectancy of greater than ten years a decision should be made by the person in question. In general, they conclude that based on recent research, \"it is uncertain whether the benefits associated with PSA testing for prostate cancer screening are worth the harms associated with screening and subsequent unnecessary treatment.\"<sup id=\"cite_ref-7\" class=\"reference\"><a href=\"#cite_note-7\">&#91;7&#93;</a></sup>\n</p><p><a href=\"/wiki/Prostate_biopsy\" title=\"Prostate biopsy\">Prostate biopsies</a> are used to diagnose prostate cancer but are not done on asymptomatic men and therefore are not used for screening. Biopsies of prostate cancer are the gold standard in detecting prostate cancer.<sup id=\"cite_ref-Borghesi_2017_8-0\" class=\"reference\"><a href=\"#cite_note-Borghesi_2017-8\">&#91;8&#93;</a></sup><sup id=\"cite_ref-:2_9-0\" class=\"reference\"><a href=\"#cite_note-:2-9\">&#91;9&#93;</a></sup> Infections after prostate biopsy occurs in about 1% will death occurs as a result of biopsy occurs in 0.2%.<sup id=\"cite_ref-:3_10-0\" class=\"reference\"><a href=\"#cite_note-:3-10\">&#91;10&#93;</a></sup><sup id=\"cite_ref-CMAJ2014_11-0\" class=\"reference\"><a href=\"#cite_note-CMAJ2014-11\">&#91;11&#93;</a></sup> Prostate biopsy guided by <a href=\"/wiki/Magnetic_resonance_imaging\" title=\"Magnetic resonance imaging\">magnetic resonance imaging</a> has improved the diagnostic accuracy of the procedure.<sup id=\"cite_ref-:4_12-0\" class=\"reference\"><a href=\"#cite_note-:4-12\">&#91;12&#93;</a></sup><sup id=\"cite_ref-:5_13-0\" class=\"reference\"><a href=\"#cite_note-:5-13\">&#91;13&#93;</a></sup>\n</p>\n<div id=\"toc\" class=\"toc\"><input type=\"checkbox\" role=\"button\" id=\"toctogglecheckbox\" class=\"toctogglecheckbox\" style=\"display:none\" /><div class=\"toctitle\" lang=\"en\" dir=\"ltr\"><h2>Contents</h2><span class=\"toctogglespan\"><label class=\"toctogglelabel\" for=\"toctogglecheckbox\"></label></span></div>\n<ul>\n<li class=\"toclevel-1 tocsection-1\"><a href=\"#Prostate-specific_antigen\"><span class=\"tocnumber\">1</span> <span class=\"toctext\">Prostate-specific antigen</span></a></li>\n<li class=\"toclevel-1 tocsection-2\"><a href=\"#Digital_rectal_examination\"><span class=\"tocnumber\">2</span> <span class=\"toctext\">Digital rectal examination</span></a></li>\n<li class=\"toclevel-1 tocsection-3\"><a href=\"#Follow_up_tests\"><span class=\"tocnumber\">3</span> <span class=\"toctext\">Follow up tests</span></a>\n<ul>\n<li class=\"toclevel-2 tocsection-4\"><a href=\"#Biopsy\"><span class=\"tocnumber\">3.1</span> <span class=\"toctext\">Biopsy</span></a></li>\n<li class=\"toclevel-2 tocsection-5\"><a href=\"#Ultrasound\"><span class=\"tocnumber\">3.2</span> <span class=\"toctext\">Ultrasound</span></a></li>\n<li class=\"toclevel-2 tocsection-6\"><a href=\"#Magnetic_imaging\"><span class=\"tocnumber\">3.3</span> <span class=\"toctext\">Magnetic imaging</span></a></li>\n<li class=\"toclevel-2 tocsection-7\"><a href=\"#Other_imaging\"><span class=\"tocnumber\">3.4</span> <span class=\"toctext\">Other imaging</span></a></li>\n<li class=\"toclevel-2 tocsection-8\"><a href=\"#Other\"><span class=\"tocnumber\">3.5</span> <span class=\"toctext\">Other</span></a></li>\n</ul>\n</li>\n<li class=\"toclevel-1 tocsection-9\"><a href=\"#Guidelines\"><span class=\"tocnumber\">4</span> <span class=\"toctext\">Guidelines</span></a></li>\n<li class=\"toclevel-1 tocsection-10\"><a href=\"#Controversy\"><span class=\"tocnumber\">5</span> <span class=\"toctext\">Controversy</span></a></li>\n<li class=\"toclevel-1 tocsection-11\"><a href=\"#History\"><span class=\"tocnumber\">6</span> <span class=\"toctext\">History</span></a></li>\n<li class=\"toclevel-1 tocsection-12\"><a href=\"#See_also\"><span class=\"tocnumber\">7</span> <span class=\"toctext\">See also</span></a></li>\n<li class=\"toclevel-1 tocsection-13\"><a href=\"#References\"><span class=\"tocnumber\">8</span> <span class=\"toctext\">References</span></a></li>\n</ul>\n</div>\n\n<h2><span class=\"mw-headline\" id=\"Prostate-specific_antigen\">Prostate-specific antigen</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Prostate_cancer_screening&amp;action=edit&amp;section=1\" title=\"Edit section: Prostate-specific antigen\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<div class=\"thumb tright\"><div class=\"thumbinner\" style=\"width:222px;\"><a href=\"/wiki/File:PSA_KLK3_PDB_2ZCK.png\" class=\"image\"><img alt=\"\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/b/b9/PSA_KLK3_PDB_2ZCK.png/220px-PSA_KLK3_PDB_2ZCK.png\" width=\"220\" height=\"168\" class=\"thumbimage\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/b/b9/PSA_KLK3_PDB_2ZCK.png/330px-PSA_KLK3_PDB_2ZCK.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/b/b9/PSA_KLK3_PDB_2ZCK.png/440px-PSA_KLK3_PDB_2ZCK.png 2x\" data-file-width=\"1200\" data-file-height=\"919\" /></a>  <div class=\"thumbcaption\"><div class=\"magnify\"><a href=\"/wiki/File:PSA_KLK3_PDB_2ZCK.png\" class=\"internal\" title=\"Enlarge\"></a></div>Prostate-specific antigen</div></div></div>\n<p><a href=\"/wiki/Prostate-specific_antigen\" title=\"Prostate-specific antigen\">Prostate-specific antigen</a> (PSA) is secreted by the <a href=\"/wiki/Epithelium\" title=\"Epithelium\">epithelial cells</a> of the <a href=\"/wiki/Prostate\" title=\"Prostate\">prostate</a> gland and can be detected in a sample of blood.<sup id=\"cite_ref-14\" class=\"reference\"><a href=\"#cite_note-14\">&#91;14&#93;</a></sup> PSA is present in small quantities in the <a href=\"/wiki/Blood_plasma\" title=\"Blood plasma\">serum</a> of men with healthy prostates, but is often elevated in the presence of <a href=\"/wiki/Prostate_cancer\" title=\"Prostate cancer\">prostate cancer</a> or other prostate disorders.<sup id=\"cite_ref-15\" class=\"reference\"><a href=\"#cite_note-15\">&#91;15&#93;</a></sup> PSA is not a unique indicator of prostate cancer, but may also detect <a href=\"/wiki/Prostatitis\" title=\"Prostatitis\">prostatitis</a> or <a href=\"/wiki/Benign_prostatic_hyperplasia\" title=\"Benign prostatic hyperplasia\">benign prostatic hyperplasia</a>.<sup id=\"cite_ref-pmid23708103_16-0\" class=\"reference\"><a href=\"#cite_note-pmid23708103-16\">&#91;16&#93;</a></sup>\n</p><p>A 2018 <a href=\"/wiki/United_States_Preventive_Services_Task_Force\" title=\"United States Preventive Services Task Force\">United States Preventive Services Task Force</a> (USPSTF) draft reversed the prior opposition to PSA screening.<sup id=\"cite_ref-Catalona2018_17-0\" class=\"reference\"><a href=\"#cite_note-Catalona2018-17\">&#91;17&#93;</a></sup> The draft recommendations suggest shared decision making regarding screening in healthy males 55 to 69 years of age.<sup id=\"cite_ref-Catalona2018_17-1\" class=\"reference\"><a href=\"#cite_note-Catalona2018-17\">&#91;17&#93;</a></sup> The final recommendation for that age group states screening should only be done in those who wish it.<sup id=\"cite_ref-Gross2018_18-0\" class=\"reference\"><a href=\"#cite_note-Gross2018-18\">&#91;18&#93;</a></sup> In those 70 and over screening remains not recommended.<sup id=\"cite_ref-Gross2018_18-1\" class=\"reference\"><a href=\"#cite_note-Gross2018-18\">&#91;18&#93;</a></sup>\n</p><p>Screening with PSA has been associated with a number of harms including <a href=\"/wiki/Over-diagnosis\" class=\"mw-redirect\" title=\"Over-diagnosis\">over-diagnosis</a>, increased <a href=\"/wiki/Prostate_biopsy\" title=\"Prostate biopsy\">prostate biopsy</a> with associated harms, increased anxiety, and unneeded treatment.<sup id=\"cite_ref-19\" class=\"reference\"><a href=\"#cite_note-19\">&#91;19&#93;</a></sup>\n</p><p>On the other hand, up to 25% of men diagnosed in their 70s or even 80s die of prostate cancer, <i>if</i> they have high-grade (i.e., aggressive) prostate cancer.<sup id=\"cite_ref-20\" class=\"reference\"><a href=\"#cite_note-20\">&#91;20&#93;</a></sup> Conversely, some argue against PSA testing for men who are too young, because too many men would have to be screened to find one cancer, and too many men would have treatment for cancer that would not progress. Low-risk prostate cancer does not always require immediate treatment, but may be amenable to active surveillance.<sup id=\"cite_ref-Cooperberg_MR_2011_21-0\" class=\"reference\"><a href=\"#cite_note-Cooperberg_MR_2011-21\">&#91;21&#93;</a></sup> A PSA test cannot 'prove' the existence prostate cancer by itself. Varying levels of the antigen can be due to other causes.<sup id=\"cite_ref-:8_22-0\" class=\"reference\"><a href=\"#cite_note-:8-22\">&#91;22&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Digital_rectal_examination\">Digital rectal examination</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Prostate_cancer_screening&amp;action=edit&amp;section=2\" title=\"Edit section: Digital rectal examination\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>During a digital <a href=\"/wiki/Rectal_examination\" title=\"Rectal examination\">rectal examination</a> (DRE), a healthcare provider slides a gloved finger into the <a href=\"/wiki/Rectum\" title=\"Rectum\">rectum</a> and presses on the prostate, to check its size and to see whether any lumps are present.\n</p><p>A 2018 review recommended against primary care screening for prostate cancer with DRE due to the lack of evidence of the effectiveness of the practice.<sup id=\"cite_ref-Naji2018_23-0\" class=\"reference\"><a href=\"#cite_note-Naji2018-23\">&#91;23&#93;</a></sup> If a digital exam suggests anomalies, a PSA screening is then performed. If an elevated PSA level is found, a digital exam is then performed.<sup id=\"cite_ref-NCI_2-2\" class=\"reference\"><a href=\"#cite_note-NCI-2\">&#91;2&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Follow_up_tests\">Follow up tests</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Prostate_cancer_screening&amp;action=edit&amp;section=3\" title=\"Edit section: Follow up tests\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<h3><span class=\"mw-headline\" id=\"Biopsy\">Biopsy</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Prostate_cancer_screening&amp;action=edit&amp;section=4\" title=\"Edit section: Biopsy\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p><a href=\"/wiki/Prostate_biopsy\" title=\"Prostate biopsy\">Prostate biopsies</a> are considered the gold standard in detecting prostate cancer.<sup id=\"cite_ref-Borghesi_2017_8-1\" class=\"reference\"><a href=\"#cite_note-Borghesi_2017-8\">&#91;8&#93;</a></sup><sup id=\"cite_ref-:2_9-1\" class=\"reference\"><a href=\"#cite_note-:2-9\">&#91;9&#93;</a></sup> Infection is a possible risk.<sup id=\"cite_ref-:3_10-1\" class=\"reference\"><a href=\"#cite_note-:3-10\">&#91;10&#93;</a></sup> MRI guided techniques has improved the diagnostic accuracy of the procedure.<sup id=\"cite_ref-:4_12-1\" class=\"reference\"><a href=\"#cite_note-:4-12\">&#91;12&#93;</a></sup><sup id=\"cite_ref-:5_13-1\" class=\"reference\"><a href=\"#cite_note-:5-13\">&#91;13&#93;</a></sup> Biopsies can be done through the <a href=\"/wiki/Transrectal_biopsy\" title=\"Transrectal biopsy\">rectum</a> or <a href=\"/wiki/Transurethral_biopsy\" title=\"Transurethral biopsy\">penis</a>.\n</p>\n<h3><span class=\"mw-headline\" id=\"Ultrasound\">Ultrasound</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Prostate_cancer_screening&amp;action=edit&amp;section=5\" title=\"Edit section: Ultrasound\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p><a href=\"/wiki/Transrectal_ultrasonography\" title=\"Transrectal ultrasonography\">Transrectal ultrasonography</a> (TRUS) has the advantage of being fast with minimal invasive and better than MRI for the evaluation of superficial tumor.<sup id=\"cite_ref-NCI_2-3\" class=\"reference\"><a href=\"#cite_note-NCI-2\">&#91;2&#93;</a></sup> It also gives details about the layers of the rectal wall, accurate and useful for staging primary rectal cancer. While MRI is better in visualization of locally advanced and stenosing cancers. For staging perirectal lymph nodes, both TRUS and MRI are capable. TRUS has small field of view, but 3D TRUS can improve the diagnosis of anorectal diseases.<sup id=\"cite_ref-24\" class=\"reference\"><a href=\"#cite_note-24\">&#91;24&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Magnetic_imaging\">Magnetic imaging</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Prostate_cancer_screening&amp;action=edit&amp;section=6\" title=\"Edit section: Magnetic imaging\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>MRI imaging is used when screening suggests a malignancy.<sup id=\"cite_ref-:9_25-0\" class=\"reference\"><a href=\"#cite_note-:9-25\">&#91;25&#93;</a></sup> This model potentially minimizes unnecessary prostate biopsies while maximizing biopsy yield.<sup class=\"noprint Inline-Template\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Accuracy_dispute#Disputed_statement\" title=\"Wikipedia:Accuracy dispute\"><span title=\"The material near this tag is possibly inaccurate or nonfactual. (March 2018)\">dubious</span></a>&#32;<span class=\"metadata\"> &#8211; <a href=\"/wiki/Talk:Prostate_cancer_screening#Dubious\" title=\"Talk:Prostate cancer screening\">discuss</a></span></i>&#93;</sup><sup class=\"noprint Inline-Template Template-Fact\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Citation_needed\" title=\"Wikipedia:Citation needed\"><span title=\"This claim needs references to reliable sources. (March 2018)\">citation needed</span></a></i>&#93;</sup> Despite concerns about the cost of MRI scans, compared to the long-term cost burden of the PSA/TRUS biopsy-based standard of care, the imaging model has been found to be cost-effective.<sup class=\"noprint Inline-Template\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Accuracy_dispute#Disputed_statement\" title=\"Wikipedia:Accuracy dispute\"><span title=\"The material near this tag is possibly inaccurate or nonfactual. (March 2018)\">dubious</span></a>&#32;<span class=\"metadata\"> &#8211; <a href=\"/wiki/Talk:Prostate_cancer_screening#Dubious\" title=\"Talk:Prostate cancer screening\">discuss</a></span></i>&#93;</sup><sup class=\"noprint Inline-Template Template-Fact\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Citation_needed\" title=\"Wikipedia:Citation needed\"><span title=\"This claim needs references to reliable sources. (March 2018)\">citation needed</span></a></i>&#93;</sup> MRI imaging can be used for patients who have had a previous negative biopsy but their PSA continues to increase.<sup id=\"cite_ref-TurkbeyChoyke2018_26-0\" class=\"reference\"><a href=\"#cite_note-TurkbeyChoyke2018-26\">&#91;26&#93;</a></sup> Consensus has not been determined as to which of the MRI-targeted biopsy techniques is more useful.<sup id=\"cite_ref-GigantiMoore2017_27-0\" class=\"reference\"><a href=\"#cite_note-GigantiMoore2017-27\">&#91;27&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Other_imaging\">Other imaging</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Prostate_cancer_screening&amp;action=edit&amp;section=7\" title=\"Edit section: Other imaging\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p><sup>68</sup>Ga-PSMA PET/CT imaging has become in a relatively short period of time, the gold standard for restaging recurrent prostate cancer in clinical centers in which this imaging modality is available.<sup id=\"cite_ref-LenzoMeyrick2018_28-0\" class=\"reference\"><a href=\"#cite_note-LenzoMeyrick2018-28\">&#91;28&#93;</a></sup> It is likely to become the standard imaging modality in the staging of intermediate-to-high risk primary prostate cancer.<sup id=\"cite_ref-LenzoMeyrick2018_28-1\" class=\"reference\"><a href=\"#cite_note-LenzoMeyrick2018-28\">&#91;28&#93;</a></sup> The potential to guide therapy, and to facilitate more accurate prostatic biopsy is being explored.<sup id=\"cite_ref-LenzoMeyrick2018_28-2\" class=\"reference\"><a href=\"#cite_note-LenzoMeyrick2018-28\">&#91;28&#93;</a></sup> In the theranostic paradigm, <sup>68</sup>Ga-PSMA PET/CT imaging is critical for detecting prostate specific membrane antigen-avid disease which may then respond to targeted <sup>177</sup>Lu-PSMA or <sup>225</sup>Ac-PSMA therapies.<sup id=\"cite_ref-LenzoMeyrick2018_28-3\" class=\"reference\"><a href=\"#cite_note-LenzoMeyrick2018-28\">&#91;28&#93;</a></sup> For local recurrence, <sup>68</sup>Ga-PSMA PET/MR or PET/CT in combination with mpMR is most appropriate.<sup id=\"cite_ref-VirgoliniDecristoforo2018_29-0\" class=\"reference\"><a href=\"#cite_note-VirgoliniDecristoforo2018-29\">&#91;29&#93;</a></sup> PSMA PET/CT may be potentially helpful for locating the cancer when combined with multiparametric MRI (mpMRI) for primary prostate care.<sup id=\"cite_ref-BoucheloucheChoyke2018_30-0\" class=\"reference\"><a href=\"#cite_note-BoucheloucheChoyke2018-30\">&#91;30&#93;</a></sup> Prostate multiparametric MR imaging (mpMRI) is helpful in evaluating recurrence of primary prostate cancer following treatment.<sup id=\"cite_ref-GaurTurkbey2018_31-0\" class=\"reference\"><a href=\"#cite_note-GaurTurkbey2018-31\">&#91;31&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Other\">Other</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Prostate_cancer_screening&amp;action=edit&amp;section=8\" title=\"Edit section: Other\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<table class=\"plainlinks metadata ambox mbox-small-left ambox-content\" role=\"presentation\"><tbody><tr><td class=\"mbox-image\"><a href=\"/wiki/File:Wiki_letter_w_cropped.svg\" class=\"image\"><img alt=\"[icon]\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/1/1c/Wiki_letter_w_cropped.svg/20px-Wiki_letter_w_cropped.svg.png\" width=\"20\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/1/1c/Wiki_letter_w_cropped.svg/30px-Wiki_letter_w_cropped.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/1/1c/Wiki_letter_w_cropped.svg/40px-Wiki_letter_w_cropped.svg.png 2x\" data-file-width=\"44\" data-file-height=\"31\" /></a></td><td class=\"mbox-text\"><div class=\"mbox-text-span\">This section <b>needs expansion</b>. <small>You can help by <a class=\"external text\" href=\"//en.wikipedia.org/w/index.php?title=Prostate_cancer_screening&amp;action=edit&amp;section=\">adding to it</a>.</small>  <small><i>(March 2018)</i></small></div></td></tr></tbody></table>\n<ul><li>The <a href=\"/w/index.php?title=Four-kallikrein_panel&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Four-kallikrein panel (page does not exist)\">four-kallikrein panel</a> (<a href=\"/wiki/OPKO_Health#4KScore\" title=\"OPKO Health\">4KScore</a>) is another test available.<sup id=\"cite_ref-RendonMason2017_32-0\" class=\"reference\"><a href=\"#cite_note-RendonMason2017-32\">&#91;32&#93;</a></sup><sup id=\"cite_ref-:9_25-1\" class=\"reference\"><a href=\"#cite_note-:9-25\">&#91;25&#93;</a></sup></li>\n<li>The <a href=\"/wiki/Prostate_health_index\" class=\"mw-redirect\" title=\"Prostate health index\">Prostate Health Index</a> (PHI) is another test available.<sup id=\"cite_ref-RendonMason2017_32-1\" class=\"reference\"><a href=\"#cite_note-RendonMason2017-32\">&#91;32&#93;</a></sup><sup id=\"cite_ref-:9_25-2\" class=\"reference\"><a href=\"#cite_note-:9-25\">&#91;25&#93;</a></sup></li>\n<li>Prostate cancer antigen 3 (<a href=\"/wiki/PCA3\" title=\"PCA3\">PCA3</a>) is another test available.<sup id=\"cite_ref-RendonMason2017_32-2\" class=\"reference\"><a href=\"#cite_note-RendonMason2017-32\">&#91;32&#93;</a></sup><sup id=\"cite_ref-:9_25-3\" class=\"reference\"><a href=\"#cite_note-:9-25\">&#91;25&#93;</a></sup></li>\n<li>ConfirmMDx (MDxHealth) is another test available.<sup id=\"cite_ref-KretschmerTilki2017_33-0\" class=\"reference\"><a href=\"#cite_note-KretschmerTilki2017-33\">&#91;33&#93;</a></sup></li></ul>\n<h2><span class=\"mw-headline\" id=\"Guidelines\">Guidelines</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Prostate_cancer_screening&amp;action=edit&amp;section=9\" title=\"Edit section: Guidelines\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<ul><li>In 2012 the <a href=\"/wiki/United_States_Preventive_Services_Task_Force\" title=\"United States Preventive Services Task Force\">United States Preventive Services Task Force</a> (USPSTF) recommended against prostate cancer screening using PSA.<sup id=\"cite_ref-34\" class=\"reference\"><a href=\"#cite_note-34\">&#91;34&#93;</a></sup> As of 2018 a draft for new recommendations suggests that screening be individualized for those between the ages of 55 to 69. It notes a small potential decrease in the risk of dying from prostate cancer but harm from overtreatment.<sup id=\"cite_ref-USPSTF2018_35-0\" class=\"reference\"><a href=\"#cite_note-USPSTF2018-35\">&#91;35&#93;</a></sup> In those over the age of 70 PSA based screening is still recommended against.<sup id=\"cite_ref-USPSTF2018_35-1\" class=\"reference\"><a href=\"#cite_note-USPSTF2018-35\">&#91;35&#93;</a></sup></li>\n<li><a href=\"/wiki/American_Cancer_Society\" title=\"American Cancer Society\">American Cancer Society</a> \"recommends that asymptomatic men who have at least a 10-year life expectancy have an opportunity to make an informed decision with their health care provider about screening for prostate cancer after they receive information about the uncertainties, risks, and potential benefits associated with prostate cancer screening. Prostate cancer screening should not occur without an informed decision-making process. Men at average risk should receive this information beginning at age 50 years. Men in higher risk groups should receive this information before age 50 years. Men should either receive this information directly from their health care providers or be referred to reliable and culturally appropriate sources.\"<sup id=\"cite_ref-36\" class=\"reference\"><a href=\"#cite_note-36\">&#91;36&#93;</a></sup></li>\n<li>Other guidelines and centers specializing in treating prostate cancer recommend obtaining a PSA in all men at age 45.<sup id=\"cite_ref-FleshnerCarlsson2016_37-0\" class=\"reference\"><a href=\"#cite_note-FleshnerCarlsson2016-37\">&#91;37&#93;</a></sup> This is based on emerging data indicating that an increased baseline PSA can be used to detect future significant disease.<sup id=\"cite_ref-FleshnerCarlsson2016_37-1\" class=\"reference\"><a href=\"#cite_note-FleshnerCarlsson2016-37\">&#91;37&#93;</a></sup></li>\n<li>The American Urological Association Patient Guide to Prostate Cancer. The American Urological Association said in early 2009 that \"The decision to screen is one that a man should make in conjunction with his physician, and should incorporate known prostate cancer risk factors, such as family history of prostate cancer, age, ethnicity/race, and whether or not a man has had a previous negative prostate biopsy. These factors are different for every man and, therefore, the benefits of screening should be considered in the broader perspective.\"<sup id=\"cite_ref-38\" class=\"reference\"><a href=\"#cite_note-38\">&#91;38&#93;</a></sup><sup id=\"cite_ref-AUA_Patient_Guide_2008_39-0\" class=\"reference\"><a href=\"#cite_note-AUA_Patient_Guide_2008-39\">&#91;39&#93;</a></sup></li>\n<li>As of 2018, the UK <a href=\"/wiki/National_Health_Service\" title=\"National Health Service\">National Health Service</a> did not offer general PSA screening, for similar reasons to those given above.  Individuals over the age of 50 who request it can normally obtain testing covered by the NHS.<sup id=\"cite_ref-:8_22-1\" class=\"reference\"><a href=\"#cite_note-:8-22\">&#91;22&#93;</a></sup></li>\n<li>The Canadian Urological Association in 2017 suggests screening be offered as a possibility to those who are expected to live more than 10 years with the final decision based on shared decision making.<sup id=\"cite_ref-RendonMason2017_32-3\" class=\"reference\"><a href=\"#cite_note-RendonMason2017-32\">&#91;32&#93;</a></sup> They recommend a starting age for most people at 50 and age 45 among those at high risk.<sup id=\"cite_ref-RendonMason2017_32-4\" class=\"reference\"><a href=\"#cite_note-RendonMason2017-32\">&#91;32&#93;</a></sup> The Canadian Task Force on Preventive Health Care in 2014 strongly recommended against screening in those under 55 and over 70 years of age.<sup id=\"cite_ref-CMAJ2014_11-1\" class=\"reference\"><a href=\"#cite_note-CMAJ2014-11\">&#91;11&#93;</a></sup> They weekly recommended against screening among those 55-69.<sup id=\"cite_ref-CMAJ2014_11-2\" class=\"reference\"><a href=\"#cite_note-CMAJ2014-11\">&#91;11&#93;</a></sup></li>\n<li>Some men have <a href=\"/wiki/Germline_mutation\" title=\"Germline mutation\">germ-line mutations</a> associated with prostate cancer development (e.g., <a href=\"/wiki/BRCA1\" title=\"BRCA1\">BRCA</a>1, <a href=\"/wiki/BRCA2\" title=\"BRCA2\">BRCA2</a>, <a href=\"/wiki/HOXB13\" title=\"HOXB13\">HOXB13</a>). Screening and its frequency is established after consulting with a geneticist.<sup id=\"cite_ref-RendonMason2017_32-5\" class=\"reference\"><a href=\"#cite_note-RendonMason2017-32\">&#91;32&#93;</a></sup></li></ul>\n<h2><span class=\"mw-headline\" id=\"Controversy\">Controversy</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Prostate_cancer_screening&amp;action=edit&amp;section=10\" title=\"Edit section: Controversy\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>From population screening to early diagnosis there is a lack of understanding.<sup id=\"cite_ref-Sadi2017_40-0\" class=\"reference\"><a href=\"#cite_note-Sadi2017-40\">&#91;40&#93;</a></sup> Screening for prostate cancer continues to generate debate by clinicians and broader lay audiences. Publications authored by governmental, non-governmental and medical organizations continue the debate and publish recommendations for screening.<sup id=\"cite_ref-:7_3-1\" class=\"reference\"><a href=\"#cite_note-:7-3\">&#91;3&#93;</a></sup> One in six men will be diagnosed with prostate cancer during their lifetime but screening may result in the overdiagnosis and overtreatment of prostate cancer.<sup id=\"cite_ref-:6_41-0\" class=\"reference\"><a href=\"#cite_note-:6-41\">&#91;41&#93;</a></sup><sup id=\"cite_ref-42\" class=\"reference\"><a href=\"#cite_note-42\">&#91;42&#93;</a></sup> Prostate cancer screening often diagnosed in an outpatient setting making it reasonably accessible. Though the death rates from prostate cancer continue to decline, 238,590 men were diagnosed with prostate cancer in 2013 while 29,720 died as a result. Death rates from prostate cancer have declined at a steady rate since 1992. Cancers of the prostate, lung and bronchus, and colorectum account for about 50% of all newly diagnosed cancers in men. Prostate cancer alone constitutes 28% cases in men. Screening for prostate cancer varies by state and indicates differences in the use of screening for prostate cancer as well as variations between locales. Out all cases of prostate cancer, African american men have an incidence of 62%. African American men are less likely to receive standard therapy for prostate cancer. This discrepancy may indicate that if they were to receive higher quality cancer treatment their survival rates would be similar to whites.<sup id=\"cite_ref-:6_41-1\" class=\"reference\"><a href=\"#cite_note-:6-41\">&#91;41&#93;</a></sup> Prostate cancer is also extremely heterogeneous: many, perhaps most, prostate cancers are indolent and would never progress to a clinically meaningful stage if left undiagnosed and untreated during a man's lifetime. On the other hand, a subset are potentially lethal, and screening can identify some of these within a window of opportunity for cure.<sup id=\"cite_ref-43\" class=\"reference\"><a href=\"#cite_note-43\">&#91;43&#93;</a></sup> Thus, the concept of PSA screening is advocated by some as a means of detecting <i>high-risk</i>, potentially lethal prostate cancer, with the understanding that lower-risk disease, if discovered, often does not need treatment and may be amenable to active surveillance.<sup id=\"cite_ref-Cooperberg_MR_2011_21-1\" class=\"reference\"><a href=\"#cite_note-Cooperberg_MR_2011-21\">&#91;21&#93;</a></sup><sup id=\"cite_ref-44\" class=\"reference\"><a href=\"#cite_note-44\">&#91;44&#93;</a></sup>\n</p><p>Screening for prostate cancer is controversial because of cost and uncertain long-term benefits to patients.<sup id=\"cite_ref-pmid8971068_45-0\" class=\"reference\"><a href=\"#cite_note-pmid8971068-45\">&#91;45&#93;</a></sup> Horan echos that sentiment in his book.<sup id=\"cite_ref-Horan_46-0\" class=\"reference\"><a href=\"#cite_note-Horan-46\">&#91;46&#93;</a></sup>\n</p><p>Private medical institutes, such as the <a href=\"/wiki/Mayo_Clinic\" title=\"Mayo Clinic\">Mayo Clinic</a>, likewise acknowledge that \"organizations vary in their recommendations about who should \u2014 and who shouldn't \u2014 get a PSA screening test.  They conclude: \"Ultimately, whether you should have a PSA test is something you'll have to decide after discussing it with your doctor, considering your risk factors and weighing your personal preferences.\"<sup id=\"cite_ref-47\" class=\"reference\"><a href=\"#cite_note-47\">&#91;47&#93;</a></sup>\n</p><p>A study in Europe resulted in only a small decline in death rates and concluded that 48 men would need to be treated to save one life. But of the 47 men who were treated, most would be unable to ever again function sexually and require more frequent trips to the bathroom.<sup id=\"cite_ref-Horan_46-1\" class=\"reference\"><a href=\"#cite_note-Horan-46\">&#91;46&#93;</a></sup> Aggressive marketing of screening tests by drug companies has also generated controversy as has the advocacy of testing by the <a href=\"/wiki/American_Urological_Association\" title=\"American Urological Association\">American Urological Association</a>.<sup id=\"cite_ref-Horan_46-2\" class=\"reference\"><a href=\"#cite_note-Horan-46\">&#91;46&#93;</a></sup>\n</p><p>One commentator has observed: \u201c[I]t is prudent only to use a single PSA determination as a baseline, with biopsy and cancer treatment reserved for those with significant PSA changes over time, or for those with clinical manifestations mandating immediate therapy..... absolute levels of PSA are rarely meaningful; it is the relative change in PSA levels over time that provides insight, but not definitive proof of a cancerous condition necessitating therapy.\u201c<sup id=\"cite_ref-48\" class=\"reference\"><a href=\"#cite_note-48\">&#91;48&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"History\">History</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Prostate_cancer_screening&amp;action=edit&amp;section=11\" title=\"Edit section: History\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<div class=\"thumb tright\"><div class=\"thumbinner\" style=\"width:602px;\"><a href=\"/wiki/File:Prostate_cancer_global_epidemiology.png\" class=\"image\"><img alt=\"\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/b/bf/Prostate_cancer_global_epidemiology.png/600px-Prostate_cancer_global_epidemiology.png\" width=\"600\" height=\"224\" class=\"thumbimage\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/b/bf/Prostate_cancer_global_epidemiology.png/900px-Prostate_cancer_global_epidemiology.png 1.5x, //upload.wikimedia.org/wikipedia/commons/b/bf/Prostate_cancer_global_epidemiology.png 2x\" data-file-width=\"1157\" data-file-height=\"432\" /></a>  <div class=\"thumbcaption\"><div class=\"magnify\"><a href=\"/wiki/File:Prostate_cancer_global_epidemiology.png\" class=\"internal\" title=\"Enlarge\"></a></div>Global comparisons of prostate cancer screening</div></div></div>\n<p>As early as the 1990s, prostate screening of PSA was done. In the European Randomized Study of Screening for Prostate Cancer (ERSPC) initiated in the early 1990s, the researchers concluded that PSA-based screening did reduce the rate of death from prostate cancer but instead created a high risk of overdiagnosis, i.e., 1410 men would need to be screened and 48 additional cases of prostate cancer would need to be treated to prevent just one death from prostate cancer within 9 years.<sup id=\"cite_ref-Schr\u00f6der,_1320_49-0\" class=\"reference\"><a href=\"#cite_note-Schr\u00f6der,_1320-49\">&#91;49&#93;</a></sup>\n</p><p>A study published in the European Journal of Cancer (October 2009) documented that prostate cancer screening reduced prostate cancer mortality by 37 percent. By utilizing a control group of men from Northern Ireland, where PSA screening is infrequent, the research showed this substantial reduction in prostate cancer deaths when compared to men who were PSA tested as part of the ERSPC study.<sup id=\"cite_ref-Prostatecancer_50-0\" class=\"reference\"><a href=\"#cite_note-Prostatecancer-50\">&#91;50&#93;</a></sup>\n</p><p>A study published in the <a href=\"/wiki/New_England_Journal_of_Medicine\" class=\"mw-redirect\" title=\"New England Journal of Medicine\">New England Journal of Medicine</a> in 2009, found that over a 7 to 10-year period, \"screening did not reduce the death rate in men 55 and over.\"<sup id=\"cite_ref-Horan_46-3\" class=\"reference\"><a href=\"#cite_note-Horan-46\">&#91;46&#93;</a></sup> Former screening proponents, including some from Stanford University, have come out against routine testing. In February 2010, the <a href=\"/wiki/American_Cancer_Society\" title=\"American Cancer Society\">American Cancer Society</a> urged \"more caution in using the test.\" And the <a href=\"/wiki/American_College_of_Preventive_Medicine\" title=\"American College of Preventive Medicine\">American College of Preventive Medicine</a> concluded that \"there was insufficient evidence to recommend routine screening.\"<sup id=\"cite_ref-Horan_46-4\" class=\"reference\"><a href=\"#cite_note-Horan-46\">&#91;46&#93;</a></sup>\n</p><p>A further study, the <a href=\"/wiki/National_Health_Service\" title=\"National Health Service\">NHS</a> Comparison Arm for ProtecT (CAP) as part of the  Prostate testing for cancer and Treatment (ProtecT) study randomized <a href=\"/wiki/Healthcare_in_the_United_Kingdom#GP\" class=\"mw-redirect\" title=\"Healthcare in the United Kingdom\">GP</a> practices with 460,000 men aged 50\u201369 at centers in 9 cities in Britain from 2001-2005 to usual care or prostate cancer screening with PSA (biopsy if PSA \u2265 3).df.<sup id=\"cite_ref-ProtecT_51-0\" class=\"reference\"><a href=\"#cite_note-ProtecT-51\">&#91;51&#93;</a></sup> The \"Comparison Arm\" has yet to report as of early 2018.<sup id=\"cite_ref-52\" class=\"reference\"><a href=\"#cite_note-52\">&#91;52&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"See_also\">See also</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Prostate_cancer_screening&amp;action=edit&amp;section=12\" title=\"Edit section: See also\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<ul><li><a href=\"/wiki/Active_surveillance_of_prostate_cancer\" title=\"Active surveillance of prostate cancer\">Active surveillance of prostate cancer</a></li>\n<li><a href=\"/wiki/Transurethral_incision_of_the_prostate\" title=\"Transurethral incision of the prostate\">Transurethral incision of the prostate</a></li>\n<li><a href=\"/wiki/Transurethral_biopsy\" title=\"Transurethral biopsy\">Transurethral biopsy</a></li></ul>\n<h2><span class=\"mw-headline\" id=\"References\">References</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Prostate_cancer_screening&amp;action=edit&amp;section=13\" title=\"Edit section: References\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<div class=\"reflist\" style=\"list-style-type: decimal;\">\n<div class=\"mw-references-wrap mw-references-columns\"><ol class=\"references\">\n<li id=\"cite_note-PDQ2018-1\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-PDQ2018_1-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-PDQ2018_1-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation book\">PDQ Screening and Prevention Editorial Board (2018). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/books/NBK65945/\"><i>PDQ Cancer Information Summaries</i></a>. Bethesda (MD): National Cancer Institute (US). <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/26389383\">26389383</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=PDQ+Cancer+Information+Summaries&amp;rft.place=Bethesda+%28MD%29&amp;rft.pub=National+Cancer+Institute+%28US%29&amp;rft.date=2018&amp;rft_id=info%3Apmid%2F26389383&amp;rft.au=PDQ+Screening+and+Prevention+Editorial+Board&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK65945%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer+screening\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span><img alt=\"\" src=\"//upload.wikimedia.org/wikipedia/en/thumb/6/62/PD-icon.svg/15px-PD-icon.svg.png\" width=\"15\" height=\"15\" srcset=\"//upload.wikimedia.org/wikipedia/en/thumb/6/62/PD-icon.svg/23px-PD-icon.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/6/62/PD-icon.svg/30px-PD-icon.svg.png 2x\" data-file-width=\"196\" data-file-height=\"196\" /> <i>This article incorporates text from this source, which is in the <a href=\"/wiki/Public_domain\" title=\"Public domain\">public domain</a>.</i></span>\n</li>\n<li id=\"cite_note-NCI-2\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-NCI_2-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-NCI_2-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-NCI_2-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-NCI_2-3\"><sup><i><b>d</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.cancer.gov/types/prostate/hp/prostate-screening-pdq\">\"Prostate Cancer Screening-Professional Version\"</a>. <i>National Cancer Institute</i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2018-02-28</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=National+Cancer+Institute&amp;rft.atitle=Prostate+Cancer+Screening-Professional+Version&amp;rft_id=https%3A%2F%2Fwww.cancer.gov%2Ftypes%2Fprostate%2Fhp%2Fprostate-screening-pdq&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer+screening\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span><img alt=\"\" src=\"//upload.wikimedia.org/wikipedia/en/thumb/6/62/PD-icon.svg/15px-PD-icon.svg.png\" width=\"15\" height=\"15\" srcset=\"//upload.wikimedia.org/wikipedia/en/thumb/6/62/PD-icon.svg/23px-PD-icon.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/6/62/PD-icon.svg/30px-PD-icon.svg.png 2x\" data-file-width=\"196\" data-file-height=\"196\" /> <i>This article incorporates text from this source, which is in the <a href=\"/wiki/Public_domain\" title=\"Public domain\">public domain</a>.</i></span>\n</li>\n<li id=\"cite_note-:7-3\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-:7_3-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-:7_3-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Ilic D, Neuberger MM, Djulbegovic M, Dahm P (January 2013). \"Screening for prostate cancer\". <i>The Cochrane Database of Systematic Reviews</i> (1): CD004720. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1002/14651858.cd004720.pub3\">10.1002/14651858.cd004720.pub3</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/23440794\">23440794</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Cochrane+Database+of+Systematic+Reviews&amp;rft.atitle=Screening+for+prostate+cancer&amp;rft.issue=1&amp;rft.pages=CD004720&amp;rft.date=2013-01&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.cd004720.pub3&amp;rft_id=info%3Apmid%2F23440794&amp;rft.aulast=Ilic&amp;rft.aufirst=D&amp;rft.au=Neuberger%2C+MM&amp;rft.au=Djulbegovic%2C+M&amp;rft.au=Dahm%2C+P&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer+screening\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-4\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-4\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"https://emedicine.medscape.com/article/1967731-guidelines\">\"Prostate Cancer Guidelines\"</a>. <i>Emedicine</i>. 2017<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">18 February</span> 2018</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Emedicine&amp;rft.atitle=Prostate+Cancer+Guidelines&amp;rft.date=2017&amp;rft_id=https%3A%2F%2Femedicine.medscape.com%2Farticle%2F1967731-guidelines&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer+screening\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-5\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-5\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Greene KL, Albertsen PC, Babaian RJ, Carter HB, Gann PH, Han M, Kuban DA, Sartor AO, Stanford JL, Zietman A, Carroll P (January 2013). \"Prostate specific antigen best practice statement: 2009 update\". <i>The Journal of Urology</i>. <b>189</b> (1 Suppl): S2\u2013S11. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.juro.2012.11.014\">10.1016/j.juro.2012.11.014</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/23234625\">23234625</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Journal+of+Urology&amp;rft.atitle=Prostate+specific+antigen+best+practice+statement%3A+2009+update&amp;rft.volume=189&amp;rft.issue=1+Suppl&amp;rft.pages=S2-S11&amp;rft.date=2013-01&amp;rft_id=info%3Adoi%2F10.1016%2Fj.juro.2012.11.014&amp;rft_id=info%3Apmid%2F23234625&amp;rft.aulast=Greene&amp;rft.aufirst=KL&amp;rft.au=Albertsen%2C+PC&amp;rft.au=Babaian%2C+RJ&amp;rft.au=Carter%2C+HB&amp;rft.au=Gann%2C+PH&amp;rft.au=Han%2C+M&amp;rft.au=Kuban%2C+DA&amp;rft.au=Sartor%2C+AO&amp;rft.au=Stanford%2C+JL&amp;rft.au=Zietman%2C+A&amp;rft.au=Carroll%2C+P&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer+screening\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-6\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-6\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Wolf AM, Wender RC, Etzioni RB, Thompson IM, D'Amico AV, Volk RJ, Brooks DD, Dash C, Guessous I, Andrews K, DeSantis C, Smith RA (Mar\u2013Apr 2010). \"American Cancer Society guideline for the early detection of prostate cancer: update 2010\". <i>Ca</i>. <b>60</b> (2): 70\u201398. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.3322/caac.20066\">10.3322/caac.20066</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/20200110\">20200110</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Ca&amp;rft.atitle=American+Cancer+Society+guideline+for+the+early+detection+of+prostate+cancer%3A+update+2010&amp;rft.volume=60&amp;rft.issue=2&amp;rft.pages=70-98&amp;rft.date=2010-03%2F2010-04&amp;rft_id=info%3Adoi%2F10.3322%2Fcaac.20066&amp;rft_id=info%3Apmid%2F20200110&amp;rft.aulast=Wolf&amp;rft.aufirst=AM&amp;rft.au=Wender%2C+RC&amp;rft.au=Etzioni%2C+RB&amp;rft.au=Thompson%2C+IM&amp;rft.au=D%27Amico%2C+AV&amp;rft.au=Volk%2C+RJ&amp;rft.au=Brooks%2C+DD&amp;rft.au=Dash%2C+C&amp;rft.au=Guessous%2C+I&amp;rft.au=Andrews%2C+K&amp;rft.au=DeSantis%2C+C&amp;rft.au=Smith%2C+RA&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer+screening\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-7\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-7\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Basch E, Oliver TK, Vickers A, Thompson I, Kantoff P, Parnes H, Loblaw DA, Roth B, Williams J, Nam RK (August 2012). <a rel=\"nofollow\" class=\"external text\" href=\"http://jco.ascopubs.org/content/early/2012/07/16/JCO.2012.43.3441.full.pdf\">\"Screening for prostate cancer with prostate-specific antigen testing: American Society of Clinical Oncology Provisional Clinical Opinion\"</a> <span style=\"font-size:85%;\">(PDF)</span>. <i>Journal of Clinical Oncology</i>. <b>30</b> (24): 3020\u20135. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1200/JCO.2012.43.3441\">10.1200/JCO.2012.43.3441</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3776923\">3776923</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/22802323\">22802323</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Clinical+Oncology&amp;rft.atitle=Screening+for+prostate+cancer+with+prostate-specific+antigen+testing%3A+American+Society+of+Clinical+Oncology+Provisional+Clinical+Opinion&amp;rft.volume=30&amp;rft.issue=24&amp;rft.pages=3020-5&amp;rft.date=2012-08&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3776923&amp;rft_id=info%3Apmid%2F22802323&amp;rft_id=info%3Adoi%2F10.1200%2FJCO.2012.43.3441&amp;rft.aulast=Basch&amp;rft.aufirst=E&amp;rft.au=Oliver%2C+TK&amp;rft.au=Vickers%2C+A&amp;rft.au=Thompson%2C+I&amp;rft.au=Kantoff%2C+P&amp;rft.au=Parnes%2C+H&amp;rft.au=Loblaw%2C+DA&amp;rft.au=Roth%2C+B&amp;rft.au=Williams%2C+J&amp;rft.au=Nam%2C+RK&amp;rft_id=http%3A%2F%2Fjco.ascopubs.org%2Fcontent%2Fearly%2F2012%2F07%2F16%2FJCO.2012.43.3441.full.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer+screening\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Borghesi_2017-8\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Borghesi_2017_8-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Borghesi_2017_8-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Borghesi M, Ahmed H, Nam R, Schaeffer E, Schiavina R, Taneja S, Weidner W, Loeb S (March 2017). \"Complications After Systematic, Random, and Image-guided Prostate Biopsy\". <i>European Urology</i>. <b>71</b> (3): 353\u2013365. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.eururo.2016.08.004\">10.1016/j.eururo.2016.08.004</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/27543165\">27543165</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=European+Urology&amp;rft.atitle=Complications+After+Systematic%2C+Random%2C+and+Image-guided+Prostate+Biopsy&amp;rft.volume=71&amp;rft.issue=3&amp;rft.pages=353-365&amp;rft.date=2017-03&amp;rft_id=info%3Adoi%2F10.1016%2Fj.eururo.2016.08.004&amp;rft_id=info%3Apmid%2F27543165&amp;rft.aulast=Borghesi&amp;rft.aufirst=M&amp;rft.au=Ahmed%2C+H&amp;rft.au=Nam%2C+R&amp;rft.au=Schaeffer%2C+E&amp;rft.au=Schiavina%2C+R&amp;rft.au=Taneja%2C+S&amp;rft.au=Weidner%2C+W&amp;rft.au=Loeb%2C+S&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer+screening\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-:2-9\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-:2_9-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-:2_9-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Loeb S, Vellekoop A, Ahmed HU, Catto J, Emberton M, Nam R, Rosario DJ, Scattoni V, Lotan Y (December 2013). \"Systematic review of complications of prostate biopsy\". <i>European Urology</i>. <b>64</b> (6): 876\u201392. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.eururo.2013.05.049\">10.1016/j.eururo.2013.05.049</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/23787356\">23787356</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=European+Urology&amp;rft.atitle=Systematic+review+of+complications+of+prostate+biopsy&amp;rft.volume=64&amp;rft.issue=6&amp;rft.pages=876-92&amp;rft.date=2013-12&amp;rft_id=info%3Adoi%2F10.1016%2Fj.eururo.2013.05.049&amp;rft_id=info%3Apmid%2F23787356&amp;rft.aulast=Loeb&amp;rft.aufirst=S&amp;rft.au=Vellekoop%2C+A&amp;rft.au=Ahmed%2C+HU&amp;rft.au=Catto%2C+J&amp;rft.au=Emberton%2C+M&amp;rft.au=Nam%2C+R&amp;rft.au=Rosario%2C+DJ&amp;rft.au=Scattoni%2C+V&amp;rft.au=Lotan%2C+Y&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer+screening\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-:3-10\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-:3_10-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-:3_10-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Bennett HY, Roberts MJ, Doi SA, Gardiner RA (June 2016). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.cambridge.org/core/journals/epidemiology-and-infection/article/global-burden-of-major-infectious-complications-following-prostate-biopsy/15F4BC0A3295EFC243D0BC0CAC24CAAC\">\"The global burden of major infectious complications following prostate biopsy\"</a>. <i>Epidemiology and Infection</i>. <b>144</b> (8): 1784\u201391. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1017/S0950268815002885\">10.1017/S0950268815002885</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/26645476\">26645476</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Epidemiology+and+Infection&amp;rft.atitle=The+global+burden+of+major+infectious+complications+following+prostate+biopsy&amp;rft.volume=144&amp;rft.issue=8&amp;rft.pages=1784-91&amp;rft.date=2016-06&amp;rft_id=info%3Adoi%2F10.1017%2FS0950268815002885&amp;rft_id=info%3Apmid%2F26645476&amp;rft.aulast=Bennett&amp;rft.aufirst=HY&amp;rft.au=Roberts%2C+MJ&amp;rft.au=Doi%2C+SA&amp;rft.au=Gardiner%2C+RA&amp;rft_id=https%3A%2F%2Fwww.cambridge.org%2Fcore%2Fjournals%2Fepidemiology-and-infection%2Farticle%2Fglobal-burden-of-major-infectious-complications-following-prostate-biopsy%2F15F4BC0A3295EFC243D0BC0CAC24CAAC&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer+screening\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-CMAJ2014-11\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-CMAJ2014_11-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-CMAJ2014_11-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-CMAJ2014_11-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Bell, N; Connor Gorber, S; Shane, A; Joffres, M; Singh, H; Dickinson, J; Shaw, E; Dunfield, L; Tonelli, M; Canadian Task Force on Preventive Health, Care. (4 November 2014). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4216256\">\"Recommendations on screening for prostate cancer with the prostate-specific antigen test\"</a>. <i>CMAJ&#160;: Canadian Medical Association journal = journal de l'Association medicale canadienne</i>. <b>186</b> (16): 1225\u201334. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1503/cmaj.140703\">10.1503/cmaj.140703</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4216256\">4216256</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/25349003\">25349003</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=CMAJ+%3A+Canadian+Medical+Association+journal+%3D+journal+de+l%27Association+medicale+canadienne&amp;rft.atitle=Recommendations+on+screening+for+prostate+cancer+with+the+prostate-specific+antigen+test.&amp;rft.volume=186&amp;rft.issue=16&amp;rft.pages=1225-34&amp;rft.date=2014-11-04&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4216256&amp;rft_id=info%3Apmid%2F25349003&amp;rft_id=info%3Adoi%2F10.1503%2Fcmaj.140703&amp;rft.aulast=Bell&amp;rft.aufirst=N&amp;rft.au=Connor+Gorber%2C+S&amp;rft.au=Shane%2C+A&amp;rft.au=Joffres%2C+M&amp;rft.au=Singh%2C+H&amp;rft.au=Dickinson%2C+J&amp;rft.au=Shaw%2C+E&amp;rft.au=Dunfield%2C+L&amp;rft.au=Tonelli%2C+M&amp;rft.au=Canadian+Task+Force+on+Preventive+Health%2C+Care.&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4216256&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer+screening\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-:4-12\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-:4_12-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-:4_12-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Schoots IG, Roobol MJ, Nieboer D, Bangma CH, Steyerberg EW, Hunink MG (September 2015). \"Magnetic resonance imaging-targeted biopsy may enhance the diagnostic accuracy of significant prostate cancer detection compared to standard transrectal ultrasound-guided biopsy: a systematic review and meta-analysis\". <i>European Urology</i>. <b>68</b> (3): 438\u201350. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.eururo.2014.11.037\">10.1016/j.eururo.2014.11.037</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/25480312\">25480312</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=European+Urology&amp;rft.atitle=Magnetic+resonance+imaging-targeted+biopsy+may+enhance+the+diagnostic+accuracy+of+significant+prostate+cancer+detection+compared+to+standard+transrectal+ultrasound-guided+biopsy%3A+a+systematic+review+and+meta-analysis&amp;rft.volume=68&amp;rft.issue=3&amp;rft.pages=438-50&amp;rft.date=2015-09&amp;rft_id=info%3Adoi%2F10.1016%2Fj.eururo.2014.11.037&amp;rft_id=info%3Apmid%2F25480312&amp;rft.aulast=Schoots&amp;rft.aufirst=IG&amp;rft.au=Roobol%2C+MJ&amp;rft.au=Nieboer%2C+D&amp;rft.au=Bangma%2C+CH&amp;rft.au=Steyerberg%2C+EW&amp;rft.au=Hunink%2C+MG&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer+screening\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-:5-13\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-:5_13-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-:5_13-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Wegelin O, van Melick HH, Hooft L, Bosch JL, Reitsma HB, Barentsz JO, Somford DM (April 2017). \"Comparing Three Different Techniques for Magnetic Resonance Imaging-targeted Prostate Biopsies: A Systematic Review of In-bore versus Magnetic Resonance Imaging-transrectal Ultrasound fusion versus Cognitive Registration. Is There a Preferred Technique?\". <i>European Urology</i>. <b>71</b> (4): 517\u2013531. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.eururo.2016.07.041\">10.1016/j.eururo.2016.07.041</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/27568655\">27568655</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=European+Urology&amp;rft.atitle=Comparing+Three+Different+Techniques+for+Magnetic+Resonance+Imaging-targeted+Prostate+Biopsies%3A+A+Systematic+Review+of+In-bore+versus+Magnetic+Resonance+Imaging-transrectal+Ultrasound+fusion+versus+Cognitive+Registration.+Is+There+a+Preferred+Technique%3F&amp;rft.volume=71&amp;rft.issue=4&amp;rft.pages=517-531&amp;rft.date=2017-04&amp;rft_id=info%3Adoi%2F10.1016%2Fj.eururo.2016.07.041&amp;rft_id=info%3Apmid%2F27568655&amp;rft.aulast=Wegelin&amp;rft.aufirst=O&amp;rft.au=van+Melick%2C+HH&amp;rft.au=Hooft%2C+L&amp;rft.au=Bosch%2C+JL&amp;rft.au=Reitsma%2C+HB&amp;rft.au=Barentsz%2C+JO&amp;rft.au=Somford%2C+DM&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer+screening\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-14\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-14\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation book\">Hellstrom WJG, ed. (1999). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.andrologysociety.com/resources/handbook/ch.8.asp\">\"Chapter 8: What is the prostate and what is its function?\"</a>. <i>American Society of Andrology Handbook</i>. San Francisco: American Society of Andrology. <a href=\"/wiki/International_Standard_Book_Number\" title=\"International Standard Book Number\">ISBN</a>&#160;<a href=\"/wiki/Special:BookSources/1-891276-02-6\" title=\"Special:BookSources/1-891276-02-6\">1-891276-02-6</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.atitle=Chapter+8%3A+What+is+the+prostate+and+what+is+its+function%3F&amp;rft.btitle=American+Society+of+Andrology+Handbook&amp;rft.place=San+Francisco&amp;rft.pub=American+Society+of+Andrology&amp;rft.date=1999&amp;rft.isbn=1-891276-02-6&amp;rft_id=http%3A%2F%2Fwww.andrologysociety.com%2Fresources%2Fhandbook%2Fch.8.asp&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer+screening\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span><sup class=\"noprint Inline-Template\"><span style=\"white-space: nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Link_rot\" title=\"Wikipedia:Link rot\"><span title=\"&#160;Dead link since December 2016\">dead link</span></a></i>&#93;</span></sup></span>\n</li>\n<li id=\"cite_note-15\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-15\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Catalona WJ, Richie JP, Ahmann FR, Hudson MA, Scardino PT, Flanigan RC, deKernion JB, Ratliff TL, Kavoussi LR, Dalkin BL (May 1994). \"Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men\". <i>The Journal of Urology</i>. <b>151</b> (5): 1283\u201390. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/S0022-5347%2817%2935233-3\">10.1016/S0022-5347(17)35233-3</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/7512659\">7512659</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Journal+of+Urology&amp;rft.atitle=Comparison+of+digital+rectal+examination+and+serum+prostate+specific+antigen+in+the+early+detection+of+prostate+cancer%3A+results+of+a+multicenter+clinical+trial+of+6%2C630+men&amp;rft.volume=151&amp;rft.issue=5&amp;rft.pages=1283-90&amp;rft.date=1994-05&amp;rft_id=info%3Adoi%2F10.1016%2FS0022-5347%2817%2935233-3&amp;rft_id=info%3Apmid%2F7512659&amp;rft.aulast=Catalona&amp;rft.aufirst=WJ&amp;rft.au=Richie%2C+JP&amp;rft.au=Ahmann%2C+FR&amp;rft.au=Hudson%2C+MA&amp;rft.au=Scardino%2C+PT&amp;rft.au=Flanigan%2C+RC&amp;rft.au=deKernion%2C+JB&amp;rft.au=Ratliff%2C+TL&amp;rft.au=Kavoussi%2C+LR&amp;rft.au=Dalkin%2C+BL&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer+screening\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid23708103-16\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid23708103_16-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Velonas VM, Woo HH, dos Remedios CG, Assinder SJ (May 2013). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3709717\">\"Current status of biomarkers for prostate cancer\"</a>. <i>International Journal of Molecular Sciences</i>. <b>14</b> (6): 11034\u201360. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.3390/ijms140611034\">10.3390/ijms140611034</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3709717\">3709717</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/23708103\">23708103</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=International+Journal+of+Molecular+Sciences&amp;rft.atitle=Current+status+of+biomarkers+for+prostate+cancer&amp;rft.volume=14&amp;rft.issue=6&amp;rft.pages=11034-60&amp;rft.date=2013-05&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3709717&amp;rft_id=info%3Apmid%2F23708103&amp;rft_id=info%3Adoi%2F10.3390%2Fijms140611034&amp;rft.aulast=Velonas&amp;rft.aufirst=VM&amp;rft.au=Woo%2C+HH&amp;rft.au=dos+Remedios%2C+CG&amp;rft.au=Assinder%2C+SJ&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3709717&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer+screening\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Catalona2018-17\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Catalona2018_17-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Catalona2018_17-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Catalona WJ (March 2018). \"Prostate Cancer Screening\". <i>The Medical Clinics of North America</i>. <b>102</b> (2): 199\u2013214. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.mcna.2017.11.001\">10.1016/j.mcna.2017.11.001</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/29406053\">29406053</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Medical+Clinics+of+North+America&amp;rft.atitle=Prostate+Cancer+Screening&amp;rft.volume=102&amp;rft.issue=2&amp;rft.pages=199-214&amp;rft.date=2018-03&amp;rft_id=info%3Adoi%2F10.1016%2Fj.mcna.2017.11.001&amp;rft_id=info%3Apmid%2F29406053&amp;rft.aulast=Catalona&amp;rft.aufirst=WJ&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer+screening\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Gross2018-18\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Gross2018_18-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Gross2018_18-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Grossman, David C.; Curry, Susan J.; Owens, Douglas K.; <a href=\"/wiki/Kirsten_Bibbins-Domingo\" title=\"Kirsten Bibbins-Domingo\">Bibbins-Domingo</a>, Kirsten; Caughey, Aaron B.; Davidson, Karina W.; Doubeni, Chyke A.; Ebell, Mark; Epling, John W.; Kemper, Alex R.; Krist, Alex H.; Kubik, Martha; Landefeld, C. Seth; Mangione, Carol M.; Silverstein, Michael; Simon, Melissa A.; Siu, Albert L.; Tseng, Chien-Wen (8 May 2018). \"Screening for Prostate Cancer\". <i>JAMA</i>. <b>319</b> (18): 1901. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1001/jama.2018.3710\">10.1001/jama.2018.3710</a>. <q>Clinicians should not screen men who do not express a preference for screening.</q></cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=JAMA&amp;rft.atitle=Screening+for+Prostate+Cancer&amp;rft.volume=319&amp;rft.issue=18&amp;rft.pages=1901&amp;rft.date=2018-05-08&amp;rft_id=info%3Adoi%2F10.1001%2Fjama.2018.3710&amp;rft.aulast=Grossman&amp;rft.aufirst=David+C.&amp;rft.au=Curry%2C+Susan+J.&amp;rft.au=Owens%2C+Douglas+K.&amp;rft.au=Bibbins-Domingo%2C+Kirsten&amp;rft.au=Caughey%2C+Aaron+B.&amp;rft.au=Davidson%2C+Karina+W.&amp;rft.au=Doubeni%2C+Chyke+A.&amp;rft.au=Ebell%2C+Mark&amp;rft.au=Epling%2C+John+W.&amp;rft.au=Kemper%2C+Alex+R.&amp;rft.au=Krist%2C+Alex+H.&amp;rft.au=Kubik%2C+Martha&amp;rft.au=Landefeld%2C+C.+Seth&amp;rft.au=Mangione%2C+Carol+M.&amp;rft.au=Silverstein%2C+Michael&amp;rft.au=Simon%2C+Melissa+A.&amp;rft.au=Siu%2C+Albert+L.&amp;rft.au=Tseng%2C+Chien-Wen&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer+screening\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-19\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-19\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Stewart, Rosalyn W.; Lizama, Sergio; Peairs, Kimberly; Sateia, Heather F.; Choi, Youngjee (February 2017). \"Screening for prostate cancer\". <i>Seminars in Oncology</i>. <b>44</b> (1): 47\u201356. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1053/j.seminoncol.2017.02.001\">10.1053/j.seminoncol.2017.02.001</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/28395763\">28395763</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Seminars+in+Oncology&amp;rft.atitle=Screening+for+prostate+cancer&amp;rft.volume=44&amp;rft.issue=1&amp;rft.pages=47-56&amp;rft.date=2017-02&amp;rft_id=info%3Adoi%2F10.1053%2Fj.seminoncol.2017.02.001&amp;rft_id=info%3Apmid%2F28395763&amp;rft.aulast=Stewart&amp;rft.aufirst=Rosalyn+W.&amp;rft.au=Lizama%2C+Sergio&amp;rft.au=Peairs%2C+Kimberly&amp;rft.au=Sateia%2C+Heather+F.&amp;rft.au=Choi%2C+Youngjee&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer+screening\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-20\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-20\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Lu-Yao GL, Albertsen PC, Moore DF, Shih W, Lin Y, DiPaola RS, Barry MJ, Zietman A,  et al. (September 2009). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC2822438\">\"Outcomes of localized prostate cancer following conservative management\"</a>. <i>JAMA</i>. <b>302</b> (11): 1202\u20139. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1001/jama.2009.1348\">10.1001/jama.2009.1348</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC2822438\">2822438</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/19755699\">19755699</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=JAMA&amp;rft.atitle=Outcomes+of+localized+prostate+cancer+following+conservative+management&amp;rft.volume=302&amp;rft.issue=11&amp;rft.pages=1202-9&amp;rft.date=2009-09&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2822438&amp;rft_id=info%3Apmid%2F19755699&amp;rft_id=info%3Adoi%2F10.1001%2Fjama.2009.1348&amp;rft.aulast=Lu-Yao&amp;rft.aufirst=GL&amp;rft.au=Albertsen%2C+PC&amp;rft.au=Moore%2C+DF&amp;rft.au=Shih%2C+W&amp;rft.au=Lin%2C+Y&amp;rft.au=DiPaola%2C+RS&amp;rft.au=Barry%2C+MJ&amp;rft.au=Zietman%2C+A&amp;rft.au=O%27Leary%2C+M&amp;rft.au=Walker-Corkery%2C+E&amp;rft.au=Yao%2C+SL&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2822438&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer+screening\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Cooperberg_MR_2011-21\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Cooperberg_MR_2011_21-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Cooperberg_MR_2011_21-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Cooperberg MR, Carroll PR, Klotz L (September 2011). \"Active surveillance for prostate cancer: progress and promise\". <i>Journal of Clinical Oncology</i>. <b>29</b> (27): 3669\u201376. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1200/JCO.2011.34.9738\">10.1200/JCO.2011.34.9738</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/21825257\">21825257</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Clinical+Oncology&amp;rft.atitle=Active+surveillance+for+prostate+cancer%3A+progress+and+promise&amp;rft.volume=29&amp;rft.issue=27&amp;rft.pages=3669-76&amp;rft.date=2011-09&amp;rft_id=info%3Adoi%2F10.1200%2FJCO.2011.34.9738&amp;rft_id=info%3Apmid%2F21825257&amp;rft.aulast=Cooperberg&amp;rft.aufirst=MR&amp;rft.au=Carroll%2C+PR&amp;rft.au=Klotz%2C+L&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer+screening\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-:8-22\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-:8_22-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-:8_22-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.nhs.uk/Conditions/Cancer-of-the-prostate/Pages/Prevention.aspx\">\"Prostate cancer - PSA testing - NHS Choices\"</a>. NHS Choices. 3 January 2015.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Prostate+cancer+-+PSA+testing+-+NHS+Choices&amp;rft.pub=NHS+Choices&amp;rft.date=2015-01-03&amp;rft_id=http%3A%2F%2Fwww.nhs.uk%2FConditions%2FCancer-of-the-prostate%2FPages%2FPrevention.aspx&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer+screening\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Naji2018-23\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Naji2018_23-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Naji, Leen; Randhawa, Harkanwal; Sohani, Zahra; Dennis, Brittany; Lautenbach, Deanna; Kavanagh, Owen; Bawor, Monica; Banfield, Laura; Profetto, Jason (12 March 2018). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.annfammed.org/content/16/2/149.long\">\"Digital Rectal Examination for Prostate Cancer Screening in Primary Care: A Systematic Review and Meta-Analysis\"</a>. <i>The Annals of Family Medicine</i>. <b>16</b> (2): 149\u2013154. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1370/afm.2205\">10.1370/afm.2205</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC5847354\">5847354</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/29531107\">29531107</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Annals+of+Family+Medicine&amp;rft.atitle=Digital+Rectal+Examination+for+Prostate+Cancer+Screening+in+Primary+Care%3A+A+Systematic+Review+and+Meta-Analysis&amp;rft.volume=16&amp;rft.issue=2&amp;rft.pages=149-154&amp;rft.date=2018-03-12&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5847354&amp;rft_id=info%3Apmid%2F29531107&amp;rft_id=info%3Adoi%2F10.1370%2Fafm.2205&amp;rft.aulast=Naji&amp;rft.aufirst=Leen&amp;rft.au=Randhawa%2C+Harkanwal&amp;rft.au=Sohani%2C+Zahra&amp;rft.au=Dennis%2C+Brittany&amp;rft.au=Lautenbach%2C+Deanna&amp;rft.au=Kavanagh%2C+Owen&amp;rft.au=Bawor%2C+Monica&amp;rft.au=Banfield%2C+Laura&amp;rft.au=Profetto%2C+Jason&amp;rft_id=http%3A%2F%2Fwww.annfammed.org%2Fcontent%2F16%2F2%2F149.long&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer+screening\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-24\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-24\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Kim MJ (January 2015). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4282231\">\"Transrectal ultrasonography of anorectal diseases: advantages and disadvantages\"</a>. <i>Ultrasonography</i>. <b>34</b> (1): 19\u201331. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.14366/usg.14051\">10.14366/usg.14051</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4282231\">4282231</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/25492891\">25492891</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Ultrasonography&amp;rft.atitle=Transrectal+ultrasonography+of+anorectal+diseases%3A+advantages+and+disadvantages&amp;rft.volume=34&amp;rft.issue=1&amp;rft.pages=19-31&amp;rft.date=2015-01&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4282231&amp;rft_id=info%3Apmid%2F25492891&amp;rft_id=info%3Adoi%2F10.14366%2Fusg.14051&amp;rft.aulast=Kim&amp;rft.aufirst=MJ&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4282231&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer+screening\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-:9-25\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-:9_25-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-:9_25-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-:9_25-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-:9_25-3\"><sup><i><b>d</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Sarkar S, Das S (2016-03-02). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4777886\">\"A Review of Imaging Methods for Prostate Cancer Detection\"</a>. <i>Biomedical Engineering and Computational Biology</i>. <b>7</b> (Suppl 1): 1\u201315. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.4137/BECB.S34255\">10.4137/BECB.S34255</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4777886\">4777886</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/26966397\">26966397</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Biomedical+Engineering+and+Computational+Biology&amp;rft.atitle=A+Review+of+Imaging+Methods+for+Prostate+Cancer+Detection&amp;rft.volume=7&amp;rft.issue=Suppl+1&amp;rft.pages=1-15&amp;rft.date=2016-03-02&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4777886&amp;rft_id=info%3Apmid%2F26966397&amp;rft_id=info%3Adoi%2F10.4137%2FBECB.S34255&amp;rft.aulast=Sarkar&amp;rft.aufirst=S&amp;rft.au=Das%2C+S&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4777886&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer+screening\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-TurkbeyChoyke2018-26\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-TurkbeyChoyke2018_26-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Turkbey, Baris; Choyke, Peter L. (2018). \"Future Perspectives and Challenges of Prostate MR Imaging\". <i>Radiologic Clinics of North America</i>. <b>56</b> (2): 327\u2013337. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.rcl.2017.10.013\">10.1016/j.rcl.2017.10.013</a>. <a href=\"/wiki/International_Standard_Serial_Number\" title=\"International Standard Serial Number\">ISSN</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.worldcat.org/issn/0033-8389\">0033-8389</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Radiologic+Clinics+of+North+America&amp;rft.atitle=Future+Perspectives+and+Challenges+of+Prostate+MR+Imaging&amp;rft.volume=56&amp;rft.issue=2&amp;rft.pages=327-337&amp;rft.date=2018&amp;rft_id=info%3Adoi%2F10.1016%2Fj.rcl.2017.10.013&amp;rft.issn=0033-8389&amp;rft.aulast=Turkbey&amp;rft.aufirst=Baris&amp;rft.au=Choyke%2C+Peter+L.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer+screening\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-GigantiMoore2017-27\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-GigantiMoore2017_27-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Giganti, Francesco; Moore, Caroline M. (2017). \"A critical comparison of techniques for MRI-targeted biopsy of the prostate\". <i>Translational Andrology and Urology</i>. <b>6</b> (3): 432\u2013443. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.21037/tau.2017.03.77\">10.21037/tau.2017.03.77</a>. <a href=\"/wiki/International_Standard_Serial_Number\" title=\"International Standard Serial Number\">ISSN</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.worldcat.org/issn/2223-4683\">2223-4683</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Translational+Andrology+and+Urology&amp;rft.atitle=A+critical+comparison+of+techniques+for+MRI-targeted+biopsy+of+the+prostate&amp;rft.volume=6&amp;rft.issue=3&amp;rft.pages=432-443&amp;rft.date=2017&amp;rft_id=info%3Adoi%2F10.21037%2Ftau.2017.03.77&amp;rft.issn=2223-4683&amp;rft.aulast=Giganti&amp;rft.aufirst=Francesco&amp;rft.au=Moore%2C+Caroline+M.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer+screening\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-LenzoMeyrick2018-28\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-LenzoMeyrick2018_28-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-LenzoMeyrick2018_28-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-LenzoMeyrick2018_28-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-LenzoMeyrick2018_28-3\"><sup><i><b>d</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Lenzo NP, Meyrick D, Turner JH (February 2018). \"Review of Gallium-68 PSMA PET/CT Imaging in the Management of Prostate Cancer\". <i>Diagnostics</i>. <b>8</b> (1): 16. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.3390/diagnostics8010016\">10.3390/diagnostics8010016</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/29439481\">29439481</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Diagnostics&amp;rft.atitle=Review+of+Gallium-68+PSMA+PET%2FCT+Imaging+in+the+Management+of+Prostate+Cancer&amp;rft.volume=8&amp;rft.issue=1&amp;rft.pages=16&amp;rft.date=2018-02&amp;rft_id=info%3Adoi%2F10.3390%2Fdiagnostics8010016&amp;rft_id=info%3Apmid%2F29439481&amp;rft.aulast=Lenzo&amp;rft.aufirst=NP&amp;rft.au=Meyrick%2C+D&amp;rft.au=Turner%2C+JH&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer+screening\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span><i><a href=\"//creativecommons.org/licenses/by/4.0/\" title=\"creativecommons:by/4.0/\"><img alt=\"\" src=\"//upload.wikimedia.org/wikipedia/commons/b/b1/CC-BY-icon-80x15.png\" width=\"80\" height=\"15\" data-file-width=\"80\" data-file-height=\"15\" /></a>&#160;This article incorporates <a rel=\"nofollow\" class=\"external text\" href=\"http://www.mdpi.com/2075-4418/8/1/16/htm\">text</a>&#32;by Nat P. Lenzo, Danielle Meyrick, and J. Harvey Turner available under the <a href=\"//creativecommons.org/licenses/by/4.0/\" class=\"extiw\" title=\"creativecommons:by/4.0/\">CC BY 4.0</a> license.</i></span>\n</li>\n<li id=\"cite_note-VirgoliniDecristoforo2018-29\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-VirgoliniDecristoforo2018_29-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Virgolini I, Decristoforo C, Haug A, Fanti S, Uprimny C (March 2018). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC5787224\">\"Current status of theranostics in prostate cancer\"</a>. <i>European Journal of Nuclear Medicine and Molecular Imaging</i>. <b>45</b> (3): 471\u2013495. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1007/s00259-017-3882-2\">10.1007/s00259-017-3882-2</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC5787224\">5787224</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/29282518\">29282518</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=European+Journal+of+Nuclear+Medicine+and+Molecular+Imaging&amp;rft.atitle=Current+status+of+theranostics+in+prostate+cancer&amp;rft.volume=45&amp;rft.issue=3&amp;rft.pages=471-495&amp;rft.date=2018-03&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5787224&amp;rft_id=info%3Apmid%2F29282518&amp;rft_id=info%3Adoi%2F10.1007%2Fs00259-017-3882-2&amp;rft.aulast=Virgolini&amp;rft.aufirst=I&amp;rft.au=Decristoforo%2C+C&amp;rft.au=Haug%2C+A&amp;rft.au=Fanti%2C+S&amp;rft.au=Uprimny%2C+C&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5787224&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer+screening\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span><i><a href=\"//creativecommons.org/licenses/by/4.0/\" title=\"creativecommons:by/4.0/\"><img alt=\"\" src=\"//upload.wikimedia.org/wikipedia/commons/b/b1/CC-BY-icon-80x15.png\" width=\"80\" height=\"15\" data-file-width=\"80\" data-file-height=\"15\" /></a>&#160;This article incorporates <a rel=\"nofollow\" class=\"external text\" href=\"https://link.springer.com/article/10.1007%2Fs00259-017-3882-2\">text</a>&#32;by Irene Virgolini, Clemens Decristoforo, Alexander Haug, Stefano Fanti, and Christian Uprimny available under the <a href=\"//creativecommons.org/licenses/by/4.0/\" class=\"extiw\" title=\"creativecommons:by/4.0/\">CC BY 4.0</a> license.</i></span>\n</li>\n<li id=\"cite_note-BoucheloucheChoyke2018-30\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-BoucheloucheChoyke2018_30-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Bouchelouche, Kirsten; Choyke, Peter L. (2018). \"Advances in prostate-specific membrane antigen PET of prostate cancer\". <i>Current Opinion in Oncology</i>: 1. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1097/CCO.0000000000000439\">10.1097/CCO.0000000000000439</a>. <a href=\"/wiki/International_Standard_Serial_Number\" title=\"International Standard Serial Number\">ISSN</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.worldcat.org/issn/1040-8746\">1040-8746</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Current+Opinion+in+Oncology&amp;rft.atitle=Advances+in+prostate-specific+membrane+antigen+PET+of+prostate+cancer&amp;rft.pages=1&amp;rft.date=2018&amp;rft_id=info%3Adoi%2F10.1097%2FCCO.0000000000000439&amp;rft.issn=1040-8746&amp;rft.aulast=Bouchelouche&amp;rft.aufirst=Kirsten&amp;rft.au=Choyke%2C+Peter+L.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer+screening\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-GaurTurkbey2018-31\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-GaurTurkbey2018_31-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Gaur, Sonia; Turkbey, Baris (2018). \"Prostate MR Imaging for Posttreatment Evaluation and Recurrence\". <i>Radiologic Clinics of North America</i>. <b>56</b> (2): 263\u2013275. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.rcl.2017.10.008\">10.1016/j.rcl.2017.10.008</a>. <a href=\"/wiki/International_Standard_Serial_Number\" title=\"International Standard Serial Number\">ISSN</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.worldcat.org/issn/0033-8389\">0033-8389</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Radiologic+Clinics+of+North+America&amp;rft.atitle=Prostate+MR+Imaging+for+Posttreatment+Evaluation+and+Recurrence&amp;rft.volume=56&amp;rft.issue=2&amp;rft.pages=263-275&amp;rft.date=2018&amp;rft_id=info%3Adoi%2F10.1016%2Fj.rcl.2017.10.008&amp;rft.issn=0033-8389&amp;rft.aulast=Gaur&amp;rft.aufirst=Sonia&amp;rft.au=Turkbey%2C+Baris&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer+screening\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-RendonMason2017-32\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-RendonMason2017_32-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-RendonMason2017_32-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-RendonMason2017_32-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-RendonMason2017_32-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-RendonMason2017_32-4\"><sup><i><b>e</b></i></sup></a> <a href=\"#cite_ref-RendonMason2017_32-5\"><sup><i><b>f</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Rendon RA, Mason RJ, Marzouk K, Finelli A, Saad F, So A, Violette P, Breau RH (October 2017). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC5659858\">\"Recommandations de l'Association des urologues du Canada sur le d\u00e9pistage et le diagnostic pr\u00e9coce du cancer de la prostate\"</a>. <i>Canadian Urological Association Journal = Journal De l'Association Des Urologues Du Canada</i>. <b>11</b> (10): 298\u2013309. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.5489/cuaj.4888\">10.5489/cuaj.4888</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC5659858\">5659858</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/29381452\">29381452</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Canadian+Urological+Association+Journal+%3D+Journal+De+l%27Association+Des+Urologues+Du+Canada&amp;rft.atitle=Recommandations+de+l%27Association+des+urologues+du+Canada+sur+le+d%C3%A9pistage+et+le+diagnostic+pr%C3%A9coce+du+cancer+de+la+prostate&amp;rft.volume=11&amp;rft.issue=10&amp;rft.pages=298-309&amp;rft.date=2017-10&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5659858&amp;rft_id=info%3Apmid%2F29381452&amp;rft_id=info%3Adoi%2F10.5489%2Fcuaj.4888&amp;rft.aulast=Rendon&amp;rft.aufirst=RA&amp;rft.au=Mason%2C+RJ&amp;rft.au=Marzouk%2C+K&amp;rft.au=Finelli%2C+A&amp;rft.au=Saad%2C+F&amp;rft.au=So%2C+A&amp;rft.au=Violette%2C+P&amp;rft.au=Breau%2C+RH&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5659858&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer+screening\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-KretschmerTilki2017-33\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-KretschmerTilki2017_33-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Kretschmer, Alexander; Tilki, Derya (2017). \"Biomarkers in prostate cancer \u2013 Current clinical utility and future perspectives\". <i>Critical Reviews in Oncology/Hematology</i>. <b>120</b>: 180\u2013193. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.critrevonc.2017.11.007\">10.1016/j.critrevonc.2017.11.007</a>. <a href=\"/wiki/International_Standard_Serial_Number\" title=\"International Standard Serial Number\">ISSN</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.worldcat.org/issn/1040-8428\">1040-8428</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Critical+Reviews+in+Oncology%2FHematology&amp;rft.atitle=Biomarkers+in+prostate+cancer+%E2%80%93+Current+clinical+utility+and+future+perspectives&amp;rft.volume=120&amp;rft.pages=180-193&amp;rft.date=2017&amp;rft_id=info%3Adoi%2F10.1016%2Fj.critrevonc.2017.11.007&amp;rft.issn=1040-8428&amp;rft.aulast=Kretschmer&amp;rft.aufirst=Alexander&amp;rft.au=Tilki%2C+Derya&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer+screening\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-34\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-34\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.uspreventiveservicestaskforce.org/Page/Document/UpdateSummaryFinal/prostate-cancer-screening\">\"Final Update Summary: Prostate Cancer: Screening - US Preventive Services Task Force\"</a>. <i>www.uspreventiveservicestaskforce.org</i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2 March</span> 2018</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=www.uspreventiveservicestaskforce.org&amp;rft.atitle=Final+Update+Summary%3A+Prostate+Cancer%3A+Screening+-+US+Preventive+Services+Task+Force&amp;rft_id=https%3A%2F%2Fwww.uspreventiveservicestaskforce.org%2FPage%2FDocument%2FUpdateSummaryFinal%2Fprostate-cancer-screening&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer+screening\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-USPSTF2018-35\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-USPSTF2018_35-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-USPSTF2018_35-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"https://screeningforprostatecancer.org/\">\"Home Page - USPSTF Draft Prostate Screening Recommendations\"</a>. <i>USPSTF Draft Prostate Screening Recommendations</i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2 March</span> 2018</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=USPSTF+Draft+Prostate+Screening+Recommendations&amp;rft.atitle=Home+Page+-+USPSTF+Draft+Prostate+Screening+Recommendations&amp;rft_id=https%3A%2F%2Fscreeningforprostatecancer.org%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer+screening\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-36\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-36\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Wolf AM, Wender RC, Etzioni RB, Thompson IM, D'Amico AV, Volk RJ, Brooks DD, Dash C, Guessous I, Andrews K, DeSantis C, Smith RA (2010). <a rel=\"nofollow\" class=\"external text\" href=\"http://mr.crossref.org/iPage?doi=10.3322%2Fcaac.20066\">\"American Cancer Society guideline for the early detection of prostate cancer: update 2010\"</a>. <i>Ca</i>. <b>60</b> (2): 70\u201398. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.3322/caac.20066\">10.3322/caac.20066</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/20200110\">20200110</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Ca&amp;rft.atitle=American+Cancer+Society+guideline+for+the+early+detection+of+prostate+cancer%3A+update+2010&amp;rft.volume=60&amp;rft.issue=2&amp;rft.pages=70-98&amp;rft.date=2010&amp;rft_id=info%3Adoi%2F10.3322%2Fcaac.20066&amp;rft_id=info%3Apmid%2F20200110&amp;rft.aulast=Wolf&amp;rft.aufirst=AM&amp;rft.au=Wender%2C+RC&amp;rft.au=Etzioni%2C+RB&amp;rft.au=Thompson%2C+IM&amp;rft.au=D%27Amico%2C+AV&amp;rft.au=Volk%2C+RJ&amp;rft.au=Brooks%2C+DD&amp;rft.au=Dash%2C+C&amp;rft.au=Guessous%2C+I&amp;rft.au=Andrews%2C+K&amp;rft.au=DeSantis%2C+C&amp;rft.au=Smith%2C+RA&amp;rft_id=http%3A%2F%2Fmr.crossref.org%2FiPage%3Fdoi%3D10.3322%252Fcaac.20066&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer+screening\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-FleshnerCarlsson2016-37\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-FleshnerCarlsson2016_37-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-FleshnerCarlsson2016_37-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Fleshner, Katherine; Carlsson, Sigrid V.; Roobol, Monique J. (2016). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC5341610\">\"The effect of the USPSTF PSA screening recommendation on prostate cancer incidence patterns in the USA\"</a>. <i>Nature Reviews Urology</i>. <b>14</b> (1): 26\u201337. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1038/nrurol.2016.251\">10.1038/nrurol.2016.251</a>. <a href=\"/wiki/International_Standard_Serial_Number\" title=\"International Standard Serial Number\">ISSN</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.worldcat.org/issn/1759-4812\">1759-4812</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC5341610\">5341610</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/27995937\">27995937</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature+Reviews+Urology&amp;rft.atitle=The+effect+of+the+USPSTF+PSA+screening+recommendation+on+prostate+cancer+incidence+patterns+in+the+USA&amp;rft.volume=14&amp;rft.issue=1&amp;rft.pages=26-37&amp;rft.date=2016&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5341610&amp;rft.issn=1759-4812&amp;rft_id=info%3Apmid%2F27995937&amp;rft_id=info%3Adoi%2F10.1038%2Fnrurol.2016.251&amp;rft.aulast=Fleshner&amp;rft.aufirst=Katherine&amp;rft.au=Carlsson%2C+Sigrid+V.&amp;rft.au=Roobol%2C+Monique+J.&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5341610&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer+screening\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-38\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-38\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20090410034622/http://www.auanet.org/content/press/press_releases/article.cfm?articleNo=106\">\"Archived copy\"</a>. Archived from <a rel=\"nofollow\" class=\"external text\" href=\"http://www.auanet.org/content/press/press_releases/article.cfm?articleNo=106\">the original</a> on 2009-04-10<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2009-11-14</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Archived+copy&amp;rft_id=http%3A%2F%2Fwww.auanet.org%2Fcontent%2Fpress%2Fpress_releases%2Farticle.cfm%3FarticleNo%3D106&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer+screening\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span> AUA statement March 2009 following publication of U.S. and European large scale screening effectiveness trial results</span>\n</li>\n<li id=\"cite_note-AUA_Patient_Guide_2008-39\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-AUA_Patient_Guide_2008_39-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a href=\"/wiki/American_Urological_Association\" title=\"American Urological Association\">AUA</a> (2008). <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20090326103155/http://www.auanet.org/guidelines/patient_guides/pc08.pdf\">\"Prostate Cancer Patient Guide\"</a> <span style=\"font-size:85%;\">(PDF)</span>. <i>AUA Patient Guidelines</i>. Archived from <a rel=\"nofollow\" class=\"external text\" href=\"http://www.auanet.org/guidelines/patient_guides/pc08.pdf\">the original</a> <span style=\"font-size:85%;\">(PDF)</span> on 2009-03-26.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=AUA+Patient+Guidelines&amp;rft.atitle=Prostate+Cancer+Patient+Guide&amp;rft.date=2008&amp;rft.au=AUA&amp;rft_id=http%3A%2F%2Fwww.auanet.org%2Fguidelines%2Fpatient_guides%2Fpc08.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer+screening\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Sadi2017-40\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Sadi2017_40-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Sadi, Marcus V. (2017). \"PSA screening for prostate cancer\". <i>Revista da Associa\u00e7\u00e3o M\u00e9dica Brasileira</i>. <b>63</b> (8): 722\u2013725. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1590/1806-9282.63.08.722\">10.1590/1806-9282.63.08.722</a>. <a href=\"/wiki/International_Standard_Serial_Number\" title=\"International Standard Serial Number\">ISSN</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.worldcat.org/issn/0104-4230\">0104-4230</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/28977112\">28977112</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Revista+da+Associa%C3%A7%C3%A3o+M%C3%A9dica+Brasileira&amp;rft.atitle=PSA+screening+for+prostate+cancer&amp;rft.volume=63&amp;rft.issue=8&amp;rft.pages=722-725&amp;rft.date=2017&amp;rft.issn=0104-4230&amp;rft_id=info%3Apmid%2F28977112&amp;rft_id=info%3Adoi%2F10.1590%2F1806-9282.63.08.722&amp;rft.aulast=Sadi&amp;rft.aufirst=Marcus+V.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer+screening\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-:6-41\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-:6_41-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-:6_41-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Siegel R, Naishadham D, Jemal A (January 2013). \"Cancer statistics, 2013\". <i>Ca</i>. <b>63</b> (1): 11\u201330. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.3322/caac.21166\">10.3322/caac.21166</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/23335087\">23335087</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Ca&amp;rft.atitle=Cancer+statistics%2C+2013&amp;rft.volume=63&amp;rft.issue=1&amp;rft.pages=11-30&amp;rft.date=2013-01&amp;rft_id=info%3Adoi%2F10.3322%2Fcaac.21166&amp;rft_id=info%3Apmid%2F23335087&amp;rft.aulast=Siegel&amp;rft.aufirst=R&amp;rft.au=Naishadham%2C+D&amp;rft.au=Jemal%2C+A&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer+screening\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-42\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-42\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Ashley VA, Joseph MB, Kamlesh KY, Shalini SY, Ashutosh KT, Joseph R (2017). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC5811879\">\"The Use of Biomarkers in Prostate Cancer Screening and Treatment\"</a>. <i>Reviews in Urology</i>. <b>19</b> (4): 221\u2013234. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.3909/riu0772\">10.3909/riu0772</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC5811879\">5811879</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/29472826\">29472826</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Reviews+in+Urology&amp;rft.atitle=The+Use+of+Biomarkers+in+Prostate+Cancer+Screening+and+Treatment&amp;rft.volume=19&amp;rft.issue=4&amp;rft.pages=221-234&amp;rft.date=2017&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5811879&amp;rft_id=info%3Apmid%2F29472826&amp;rft_id=info%3Adoi%2F10.3909%2Friu0772&amp;rft.aulast=Ashley&amp;rft.aufirst=VA&amp;rft.au=Joseph%2C+MB&amp;rft.au=Kamlesh%2C+KY&amp;rft.au=Shalini%2C+SY&amp;rft.au=Ashutosh%2C+KT&amp;rft.au=Joseph%2C+R&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5811879&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer+screening\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-43\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-43\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Esserman L, Shieh Y, Thompson I (October 2009). \"Rethinking screening for breast cancer and prostate cancer\". <i>JAMA</i>. <b>302</b> (15): 1685\u201392. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1001/jama.2009.1498\">10.1001/jama.2009.1498</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/19843904\">19843904</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=JAMA&amp;rft.atitle=Rethinking+screening+for+breast+cancer+and+prostate+cancer&amp;rft.volume=302&amp;rft.issue=15&amp;rft.pages=1685-92&amp;rft.date=2009-10&amp;rft_id=info%3Adoi%2F10.1001%2Fjama.2009.1498&amp;rft_id=info%3Apmid%2F19843904&amp;rft.aulast=Esserman&amp;rft.aufirst=L&amp;rft.au=Shieh%2C+Y&amp;rft.au=Thompson%2C+I&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer+screening\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-44\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-44\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Carroll PR, Whitson JM, Cooperberg MR (February 2011). \"Serum prostate-specific antigen for the early detection of prostate cancer: always, never, or only sometimes?\". <i>Journal of Clinical Oncology</i>. <b>29</b> (4): 345\u20137. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1200/JCO.2010.32.5308\">10.1200/JCO.2010.32.5308</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/21189396\">21189396</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Clinical+Oncology&amp;rft.atitle=Serum+prostate-specific+antigen+for+the+early+detection+of+prostate+cancer%3A+always%2C+never%2C+or+only+sometimes%3F&amp;rft.volume=29&amp;rft.issue=4&amp;rft.pages=345-7&amp;rft.date=2011-02&amp;rft_id=info%3Adoi%2F10.1200%2FJCO.2010.32.5308&amp;rft_id=info%3Apmid%2F21189396&amp;rft.aulast=Carroll&amp;rft.aufirst=PR&amp;rft.au=Whitson%2C+JM&amp;rft.au=Cooperberg%2C+MR&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer+screening\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid8971068-45\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid8971068_45-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Collins MM, Barry MJ (December 1996). \"Controversies in prostate cancer screening. Analogies to the early lung cancer screening debate\". <i>JAMA</i>. <b>276</b> (24): 1976\u20139. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1001/jama.276.24.1976\">10.1001/jama.276.24.1976</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/8971068\">8971068</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=JAMA&amp;rft.atitle=Controversies+in+prostate+cancer+screening.+Analogies+to+the+early+lung+cancer+screening+debate&amp;rft.volume=276&amp;rft.issue=24&amp;rft.pages=1976-9&amp;rft.date=1996-12&amp;rft_id=info%3Adoi%2F10.1001%2Fjama.276.24.1976&amp;rft_id=info%3Apmid%2F8971068&amp;rft.aulast=Collins&amp;rft.aufirst=MM&amp;rft.au=Barry%2C+MJ&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer+screening\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Horan-46\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Horan_46-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Horan_46-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-Horan_46-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-Horan_46-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-Horan_46-4\"><sup><i><b>e</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation book\">Anthony Horan (August 2009). <a rel=\"nofollow\" class=\"external text\" href=\"https://books.google.com/books?id=UlOUF4MpQ-8C\"><i>The Big Scare: The Business of Prostate Cancer</i></a>. STERLINGHOUSE. <a href=\"/wiki/International_Standard_Book_Number\" title=\"International Standard Book Number\">ISBN</a>&#160;<a href=\"/wiki/Special:BookSources/978-1-58501-119-3\" title=\"Special:BookSources/978-1-58501-119-3\">978-1-58501-119-3</a><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">18 August</span> 2013</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=The+Big+Scare%3A+The+Business+of+Prostate+Cancer&amp;rft.pub=STERLINGHOUSE&amp;rft.date=2009-08&amp;rft.isbn=978-1-58501-119-3&amp;rft.au=Anthony+Horan&amp;rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DUlOUF4MpQ-8C&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer+screening\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-47\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-47\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.mayoclinic.com/health/prostate-cancer/HQ01273\">\"Prostate cancer screening: Should you get a PSA test?\"</a> MayoClinic.com, updated March 6, 2010</span>\n</li>\n<li id=\"cite_note-48\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-48\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Haythorn MR, Ablin RJ (August 2011). \"Prostate-specific antigen testing across the spectrum of prostate cancer\". <i><a href=\"/wiki/Biomarkers_in_Medicine\" title=\"Biomarkers in Medicine\">Biomarkers in Medicine</a></i>. <b>5</b> (4): 515\u201326. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.2217/bmm.11.53\">10.2217/bmm.11.53</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/21861672\">21861672</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Biomarkers+in+Medicine&amp;rft.atitle=Prostate-specific+antigen+testing+across+the+spectrum+of+prostate+cancer&amp;rft.volume=5&amp;rft.issue=4&amp;rft.pages=515-26&amp;rft.date=2011-08&amp;rft_id=info%3Adoi%2F10.2217%2Fbmm.11.53&amp;rft_id=info%3Apmid%2F21861672&amp;rft.aulast=Haythorn&amp;rft.aufirst=MR&amp;rft.au=Ablin%2C+RJ&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer+screening\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Schr\u00f6der,_1320-49\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Schr\u00f6der,_1320_49-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Schr\u00f6der FH, Hugosson J, Roobol MJ, Tammela TL, Ciatto S, Nelen V, Kwiatkowski M, Lujan M, Lilja H, Zappa M, Denis LJ, Recker F, Berenguer A, M\u00e4\u00e4tt\u00e4nen L, Bangma CH, Aus G, Villers A, Rebillard X, van der Kwast T, Blijenberg BG, Moss SM, de Koning HJ, Auvinen A (March 2009). \"Screening and prostate-cancer mortality in a randomized European study\". <i>The New England Journal of Medicine</i>. <b>360</b> (13): 1320\u20138. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1056/NEJMoa0810084\">10.1056/NEJMoa0810084</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/19297566\">19297566</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+England+Journal+of+Medicine&amp;rft.atitle=Screening+and+prostate-cancer+mortality+in+a+randomized+European+study&amp;rft.volume=360&amp;rft.issue=13&amp;rft.pages=1320-8&amp;rft.date=2009-03&amp;rft_id=info%3Adoi%2F10.1056%2FNEJMoa0810084&amp;rft_id=info%3Apmid%2F19297566&amp;rft.aulast=Schr%C3%B6der&amp;rft.aufirst=FH&amp;rft.au=Hugosson%2C+J&amp;rft.au=Roobol%2C+MJ&amp;rft.au=Tammela%2C+TL&amp;rft.au=Ciatto%2C+S&amp;rft.au=Nelen%2C+V&amp;rft.au=Kwiatkowski%2C+M&amp;rft.au=Lujan%2C+M&amp;rft.au=Lilja%2C+H&amp;rft.au=Zappa%2C+M&amp;rft.au=Denis%2C+LJ&amp;rft.au=Recker%2C+F&amp;rft.au=Berenguer%2C+A&amp;rft.au=M%C3%A4%C3%A4tt%C3%A4nen%2C+L&amp;rft.au=Bangma%2C+CH&amp;rft.au=Aus%2C+G&amp;rft.au=Villers%2C+A&amp;rft.au=Rebillard%2C+X&amp;rft.au=van+der+Kwast%2C+T&amp;rft.au=Blijenberg%2C+BG&amp;rft.au=Moss%2C+SM&amp;rft.au=de+Koning%2C+HJ&amp;rft.au=Auvinen%2C+A&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer+screening\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Prostatecancer-50\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Prostatecancer_50-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">van Leeuwen PJ, Connolly D, Gavin A, Roobol MJ, Black A, Bangma CH, Schr\u00f6der FH (January 2010). \"Prostate cancer mortality in screen and clinically detected prostate cancer: estimating the screening benefit\". <i>European Journal of Cancer</i>. <b>46</b> (2): 377\u201383. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.ejca.2009.09.008\">10.1016/j.ejca.2009.09.008</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/19804966\">19804966</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=European+Journal+of+Cancer&amp;rft.atitle=Prostate+cancer+mortality+in+screen+and+clinically+detected+prostate+cancer%3A+estimating+the+screening+benefit&amp;rft.volume=46&amp;rft.issue=2&amp;rft.pages=377-83&amp;rft.date=2010-01&amp;rft_id=info%3Adoi%2F10.1016%2Fj.ejca.2009.09.008&amp;rft_id=info%3Apmid%2F19804966&amp;rft.aulast=van+Leeuwen&amp;rft.aufirst=PJ&amp;rft.au=Connolly%2C+D&amp;rft.au=Gavin%2C+A&amp;rft.au=Roobol%2C+MJ&amp;rft.au=Black%2C+A&amp;rft.au=Bangma%2C+CH&amp;rft.au=Schr%C3%B6der%2C+FH&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer+screening\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-ProtecT-51\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-ProtecT_51-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\">ProtecT (July 25, 2007). <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20071028005357/http://www.epi.bris.ac.uk/protect/\">\"ProtecT Study (Prostate testing for cancer and Treatment)\"</a>. <a href=\"/wiki/University_of_Bristol\" title=\"University of Bristol\">University of Bristol Dept. of Social Medicine</a>. Archived from <a rel=\"nofollow\" class=\"external text\" href=\"http://www.epi.bris.ac.uk/protect\">the original</a> on 2007-10-28<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2007-11-19</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=ProtecT+Study+%28Prostate+testing+for+cancer+and+Treatment%29&amp;rft.pub=University+of+Bristol+Dept.+of+Social+Medicine&amp;rft.date=2007-07-25&amp;rft.au=ProtecT&amp;rft_id=http%3A%2F%2Fwww.epi.bris.ac.uk%2Fprotect&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer+screening\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span><br />\n <cite class=\"citation web\">ISRCTN (March 6, 2006). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.controlled-trials.com/ISRCTN92187251\">\"The CAP (Comparison Arm for ProtecT) study\"</a>. isrctn.org.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=The+CAP+%28Comparison+Arm+for+ProtecT%29+study&amp;rft.pub=isrctn.org&amp;rft.date=2006-03-06&amp;rft.au=ISRCTN&amp;rft_id=http%3A%2F%2Fwww.controlled-trials.com%2FISRCTN92187251&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer+screening\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span><br />\n <cite class=\"citation web\">ISRCTN (November 19, 2007). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.controlled-trials.com/ISRCTN20141297\">\"The ProtecT trial\"</a>. isrctn.org.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=The+ProtecT+trial&amp;rft.pub=isrctn.org&amp;rft.date=2007-11-19&amp;rft.au=ISRCTN&amp;rft_id=http%3A%2F%2Fwww.controlled-trials.com%2FISRCTN20141297&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer+screening\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-52\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-52\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.bristol.ac.uk/population-health-sciences/projects/protect/about/\">\"Outline of the ProtecT study and its data and samples\"</a>, on the study website at Bristol University.</span>\n</li>\n</ol></div></div>\n<div role=\"navigation\" class=\"navbox\" aria-labelledby=\"Male_genital_surgical_and_other_procedures:_reproductive_system_(ICD-9-CM_V3_60\u201364,_ICD-10-PCS_0V)\" style=\"padding:3px\"><table class=\"nowraplinks collapsible autocollapse navbox-inner\" style=\"border-spacing:0;background:transparent;color:inherit\"><tbody><tr><th scope=\"col\" class=\"navbox-title\" colspan=\"2\"><div class=\"plainlinks hlist navbar mini\"><ul><li class=\"nv-view\"><a href=\"/wiki/Template:Male_genital_procedures\" title=\"Template:Male genital procedures\"><abbr title=\"View this template\" style=\";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\">v</abbr></a></li><li class=\"nv-talk\"><a href=\"/wiki/Template_talk:Male_genital_procedures\" title=\"Template talk:Male genital procedures\"><abbr title=\"Discuss this template\" style=\";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\">t</abbr></a></li><li class=\"nv-edit\"><a class=\"external text\" href=\"//en.wikipedia.org/w/index.php?title=Template:Male_genital_procedures&amp;action=edit\"><abbr title=\"Edit this template\" style=\";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\">e</abbr></a></li></ul></div><div id=\"Male_genital_surgical_and_other_procedures:_reproductive_system_(ICD-9-CM_V3_60\u201364,_ICD-10-PCS_0V)\" style=\"font-size:114%;margin:0 4em\">Male genital <a href=\"/wiki/Surgery\" title=\"Surgery\">surgical and other procedures</a>: <a href=\"/wiki/Reproductive_system\" title=\"Reproductive system\">reproductive system</a> (<a href=\"/wiki/ICD-9-CM_Volume_3#.2860\u201364.29_Operations_on_the_male_genital_organs\" title=\"ICD-9-CM Volume 3\">ICD-9-CM V3</a> 60\u201364, <a href=\"/wiki/ICD-10_Procedure_Coding_System\" title=\"ICD-10 Procedure Coding System\">ICD-10-PCS 0V</a>)</div></th></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Male_internal_genitalia\" class=\"mw-redirect\" title=\"Male internal genitalia\">Internal</a></th><td class=\"navbox-list navbox-odd hlist\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Prostate\" title=\"Prostate\">Prostate</a></th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><td colspan=\"2\" class=\"navbox-list navbox-odd\" style=\"width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Transurethral_incision_of_the_prostate\" title=\"Transurethral incision of the prostate\">Transurethral incision of the prostate</a></li>\n<li><a href=\"/wiki/Prostate_biopsy\" title=\"Prostate biopsy\">Prostate biopsy</a>\n<ul><li><a href=\"/wiki/Transrectal_biopsy\" title=\"Transrectal biopsy\">Transrectal biopsy</a></li>\n<li><a href=\"/wiki/Transurethral_biopsy\" title=\"Transurethral biopsy\">Transurethral biopsy</a></li></ul></li>\n<li><a href=\"/wiki/Prostatectomy\" title=\"Prostatectomy\">Prostatectomy</a>\n<ul><li><a href=\"/wiki/Transurethral_resection_of_the_prostate\" title=\"Transurethral resection of the prostate\">Transurethral resection of the prostate</a></li>\n<li><a href=\"/wiki/Radical_retropubic_prostatectomy\" title=\"Radical retropubic prostatectomy\">Radical retropubic prostatectomy</a></li></ul></li>\n<li><a href=\"/wiki/Transurethral_microwave_thermotherapy\" title=\"Transurethral microwave thermotherapy\">Transurethral microwave thermotherapy</a></li>\n<li><a href=\"/wiki/Transurethral_needle_ablation_of_the_prostate\" title=\"Transurethral needle ablation of the prostate\">Transurethral needle ablation of the prostate</a></li>\n<li><a href=\"/wiki/Brachytherapy\" title=\"Brachytherapy\">Brachytherapy</a>\n<ul><li><a href=\"/wiki/Prostate_brachytherapy\" title=\"Prostate brachytherapy\">Prostate brachytherapy</a></li></ul></li>\n<li><a href=\"/wiki/Prostate_massage\" title=\"Prostate massage\">Prostate massage</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Seminal_vesicle\" title=\"Seminal vesicle\">seminal vesicles</a>:</th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Spermatocelectomy\" title=\"Spermatocelectomy\">Spermatocelectomy</a></li></ul>\n</div></td></tr></tbody></table><div></div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Vas_deferens\" title=\"Vas deferens\">Vas deferens</a></th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Vasectomy\" title=\"Vasectomy\">Vasectomy</a></li>\n<li><a href=\"/wiki/Vasectomy_reversal\" title=\"Vasectomy reversal\">Vasectomy reversal</a>\n<ul><li><a href=\"/wiki/Vasovasostomy\" title=\"Vasovasostomy\">Vasovasostomy</a></li>\n<li><a href=\"/wiki/Vasoepididymostomy\" title=\"Vasoepididymostomy\">Vasoepididymostomy</a></li></ul></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Testicle\" title=\"Testicle\">Testes</a></th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Orchiectomy\" title=\"Orchiectomy\">Orchiectomy</a>\n<ul><li><a href=\"/wiki/Castration\" title=\"Castration\">Castration</a></li></ul></li>\n<li><a href=\"/wiki/Orchiopexy\" title=\"Orchiopexy\">Orchiopexy</a></li></ul>\n</div></td></tr></tbody></table><div></div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Male_external_genitalia\" class=\"mw-redirect\" title=\"Male external genitalia\">External</a></th><td class=\"navbox-list navbox-odd hlist\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th id=\"Penis\" scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Human_penis\" title=\"Human penis\">Penis</a></th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><td colspan=\"2\" class=\"navbox-list navbox-odd\" style=\"width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Circumcision\" title=\"Circumcision\">Circumcision</a></li>\n<li><a href=\"/wiki/Penectomy\" title=\"Penectomy\">Penectomy</a></li>\n<li><a href=\"/wiki/Penile_prosthesis\" title=\"Penile prosthesis\">Penile prosthesis</a></li>\n<li><a href=\"/wiki/Preputioplasty\" title=\"Preputioplasty\">Preputioplasty</a></li></ul>\n</div></td></tr><tr><td colspan=\"2\" class=\"navbox-list navbox-even\" style=\"width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Penile_plethysmograph\" title=\"Penile plethysmograph\">Penile plethysmograph</a></li>\n<li><a href=\"/wiki/Postage_stamp_test\" title=\"Postage stamp test\">Postage stamp test</a></li>\n<li><a href=\"/wiki/Frenuloplasty_of_prepuce_of_penis\" title=\"Frenuloplasty of prepuce of penis\">Frenuloplasty of prepuce of penis</a></li></ul>\n</div></td></tr></tbody></table><div></div></td></tr></tbody></table><div></div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Tests</th><td class=\"navbox-list navbox-odd hlist\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><td colspan=\"2\" class=\"navbox-list navbox-odd\" style=\"width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Semen_analysis\" title=\"Semen analysis\">Semen analysis</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Medical_imaging\" title=\"Medical imaging\">Medical imaging</a></th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Transscrotal_ultrasound\" class=\"mw-redirect\" title=\"Transscrotal ultrasound\">Transscrotal ultrasound</a></li></ul>\n</div></td></tr></tbody></table><div></div></td></tr></tbody></table></div>\n\n<!-- \nNewPP limit report\nParsed by mw2242\nCached time: 20180919202336\nCache expiry: 1900800\nDynamic content: false\nCPU time usage: 0.784 seconds\nReal time usage: 0.841 seconds\nPreprocessor visited node count: 3503/1000000\nPreprocessor generated node count: 0/1500000\nPost\u2010expand include size: 157623/2097152 bytes\nTemplate argument size: 3472/2097152 bytes\nHighest expansion depth: 12/40\nExpensive parser function count: 4/500\nUnstrip recursion depth: 0/20\nUnstrip post\u2010expand size: 91445/5000000 bytes\nNumber of Wikibase entities loaded: 0/400\nLua time usage: 0.433/10.000 seconds\nLua memory usage: 4.98 MB/50 MB\n-->\n<!--\nTransclusion expansion time report (%,ms,calls,template)\n100.00%  694.303      1 -total\n 72.01%  499.992      1 Template:Reflist\n 41.71%  289.588     39 Template:Cite_journal\n  8.75%   60.762      5 Template:Fix\n  7.63%   53.000     10 Template:Cite_web\n  7.45%   51.714      3 Template:Cite_book\n  6.89%   47.840      2 Template:Dubious\n  6.19%   42.994      1 Template:Infobox_diagnostic\n  6.16%   42.738      6 Template:Navbox\n  5.65%   39.206      1 Template:Infobox\n-->\n\n<!-- Saved in parser cache with key enwiki:pcache:idhash:3346770-0!canonical and timestamp 20180919202335 and revision id 860314289\n -->\n</div>"},"langlinks":[{"lang":"es","url":"https://es.wikipedia.org/wiki/Prevenci%C3%B3n_del_c%C3%A1ncer_de_pr%C3%B3stata","langname":"Spanish","autonym":"espa\u00f1ol","*":"Prevenci\u00f3n del c\u00e1ncer de pr\u00f3stata"},{"lang":"fr","url":"https://fr.wikipedia.org/wiki/D%C3%A9pistage_du_cancer_de_la_prostate","langname":"French","autonym":"fran\u00e7ais","*":"D\u00e9pistage du cancer de la prostate"}],"categories":[{"sortkey":"","hidden":"","*":"All_articles_with_dead_external_links"},{"sortkey":"","hidden":"","*":"Articles_with_dead_external_links_from_December_2016"},{"sortkey":"","hidden":"","*":"Articles_with_imported_freely_licensed_text"},{"sortkey":"","hidden":"","*":"All_accuracy_disputes"},{"sortkey":"","hidden":"","*":"Articles_with_disputed_statements_from_March_2018"},{"sortkey":"","hidden":"","*":"All_articles_with_unsourced_statements"},{"sortkey":"","hidden":"","*":"Articles_with_unsourced_statements_from_March_2018"},{"sortkey":"","hidden":"","*":"Articles_to_be_expanded_from_March_2018"},{"sortkey":"","hidden":"","*":"All_articles_to_be_expanded"},{"sortkey":"","hidden":"","*":"Articles_using_small_message_boxes"},{"sortkey":"","*":"Male_genital_surgery"},{"sortkey":"","*":"Prostatic_procedures"},{"sortkey":"","*":"Cancer_screening"},{"sortkey":"","*":"Prostate_cancer"},{"sortkey":"","*":"Men's_health"}],"links":[{"ns":14,"exists":"","*":"Category:Articles with disputed statements from March 2018"},{"ns":14,"exists":"","*":"Category:Articles with unsourced statements from March 2018"},{"ns":14,"exists":"","*":"Category:Articles to be expanded from March 2018"},{"ns":14,"exists":"","*":"Category:Articles with dead external links from December 2016"},{"ns":10,"exists":"","*":"Template:Male genital procedures"},{"ns":0,"exists":"","*":"Active surveillance of prostate cancer"},{"ns":0,"exists":"","*":"American Cancer Society"},{"ns":0,"exists":"","*":"American College of Preventive Medicine"},{"ns":0,"exists":"","*":"American Society of Clinical Oncology"},{"ns":0,"exists":"","*":"American Urological Association"},{"ns":0,"exists":"","*":"BRCA1"},{"ns":0,"exists":"","*":"BRCA2"},{"ns":0,"exists":"","*":"Benign prostatic hyperplasia"},{"ns":0,"exists":"","*":"Biomarkers in Medicine"},{"ns":0,"exists":"","*":"Blood"},{"ns":0,"exists":"","*":"Blood plasma"},{"ns":0,"exists":"","*":"Brachytherapy"},{"ns":0,"exists":"","*":"Castration"},{"ns":0,"exists":"","*":"Circumcision"},{"ns":0,"exists":"","*":"Cochrane (organisation)"},{"ns":0,"exists":"","*":"Digital object identifier"},{"ns":0,"exists":"","*":"Digital rectal examination"},{"ns":0,"exists":"","*":"Epithelium"},{"ns":0,"exists":"","*":"Frenuloplasty of prepuce of penis"},{"ns":0,"exists":"","*":"Germline mutation"},{"ns":0,"exists":"","*":"HOXB13"},{"ns":0,"exists":"","*":"Healthcare in the United Kingdom"},{"ns":0,"exists":"","*":"Human penis"},{"ns":0,"exists":"","*":"ICD-10 Procedure Coding System"},{"ns":0,"exists":"","*":"ICD-9-CM Volume 3"},{"ns":0,"exists":"","*":"International Standard Book Number"},{"ns":0,"exists":"","*":"International Standard Serial Number"},{"ns":0,"exists":"","*":"Kirsten Bibbins-Domingo"},{"ns":0,"exists":"","*":"Magnetic resonance imaging"},{"ns":0,"exists":"","*":"Male external genitalia"},{"ns":0,"exists":"","*":"Male internal genitalia"},{"ns":0,"exists":"","*":"Mayo Clinic"},{"ns":0,"exists":"","*":"Medical diagnosis"},{"ns":0,"exists":"","*":"Medical imaging"},{"ns":0,"exists":"","*":"Medical sign"},{"ns":0,"exists":"","*":"National Health Service"},{"ns":0,"exists":"","*":"New England Journal of Medicine"},{"ns":0,"exists":"","*":"OPKO Health"},{"ns":0,"exists":"","*":"Orchiectomy"},{"ns":0,"exists":"","*":"Orchiopexy"},{"ns":0,"exists":"","*":"Over-diagnosis"},{"ns":0,"exists":"","*":"PCA3"},{"ns":0,"exists":"","*":"Penectomy"},{"ns":0,"exists":"","*":"Penile plethysmograph"},{"ns":0,"exists":"","*":"Penile prosthesis"},{"ns":0,"exists":"","*":"Postage stamp test"},{"ns":0,"exists":"","*":"Preputioplasty"},{"ns":0,"exists":"","*":"Prostate"},{"ns":0,"exists":"","*":"Prostate-specific antigen"},{"ns":0,"exists":"","*":"Prostate biopsy"},{"ns":0,"exists":"","*":"Prostate brachytherapy"},{"ns":0,"exists":"","*":"Prostate cancer"},{"ns":0,"exists":"","*":"Prostate health index"},{"ns":0,"exists":"","*":"Prostate massage"},{"ns":0,"exists":"","*":"Prostatectomy"},{"ns":0,"exists":"","*":"Prostatitis"},{"ns":0,"exists":"","*":"PubMed Central"},{"ns":0,"exists":"","*":"PubMed Identifier"},{"ns":0,"exists":"","*":"Public domain"},{"ns":0,"exists":"","*":"Radical retropubic prostatectomy"},{"ns":0,"exists":"","*":"Rectal examination"},{"ns":0,"exists":"","*":"Rectum"},{"ns":0,"exists":"","*":"Reproductive system"},{"ns":0,"exists":"","*":"Screening (medicine)"},{"ns":0,"exists":"","*":"Semen analysis"},{"ns":0,"exists":"","*":"Seminal vesicle"},{"ns":0,"exists":"","*":"Shared decision-making"},{"ns":0,"exists":"","*":"Spermatocelectomy"},{"ns":0,"exists":"","*":"Surgery"},{"ns":0,"exists":"","*":"Symptoms"},{"ns":0,"exists":"","*":"Testicle"},{"ns":0,"exists":"","*":"Transrectal biopsy"},{"ns":0,"exists":"","*":"Transrectal ultrasonography"},{"ns":0,"exists":"","*":"Transscrotal ultrasound"},{"ns":0,"exists":"","*":"Transurethral biopsy"},{"ns":0,"exists":"","*":"Transurethral incision of the prostate"},{"ns":0,"exists":"","*":"Transurethral microwave thermotherapy"},{"ns":0,"exists":"","*":"Transurethral needle ablation of the prostate"},{"ns":0,"exists":"","*":"Transurethral resection of the prostate"},{"ns":0,"exists":"","*":"United States Preventive Services Task Force"},{"ns":0,"exists":"","*":"University of Bristol"},{"ns":0,"exists":"","*":"Vas deferens"},{"ns":0,"exists":"","*":"Vasectomy"},{"ns":0,"exists":"","*":"Vasectomy reversal"},{"ns":0,"exists":"","*":"Vasoepididymostomy"},{"ns":0,"exists":"","*":"Vasovasostomy"},{"ns":0,"*":"Four-kallikrein panel"},{"ns":1,"exists":"","*":"Talk:Prostate cancer screening"},{"ns":4,"exists":"","*":"Wikipedia:Accuracy dispute"},{"ns":4,"exists":"","*":"Wikipedia:Citation needed"},{"ns":4,"exists":"","*":"Wikipedia:Link rot"},{"ns":11,"exists":"","*":"Template talk:Male genital procedures"}],"templates":[{"ns":10,"exists":"","*":"Template:Infobox diagnostic"},{"ns":10,"exists":"","*":"Template:Infobox"},{"ns":10,"exists":"","*":"Template:Template other"},{"ns":10,"exists":"","*":"Template:Dubious"},{"ns":10,"exists":"","*":"Template:Fix"},{"ns":10,"exists":"","*":"Template:Category handler"},{"ns":10,"exists":"","*":"Template:Fix/category"},{"ns":10,"exists":"","*":"Template:Delink"},{"ns":10,"exists":"","*":"Template:Citation needed"},{"ns":10,"exists":"","*":"Template:Expand section"},{"ns":10,"exists":"","*":"Template:Ambox"},{"ns":10,"exists":"","*":"Template:Reflist"},{"ns":10,"exists":"","*":"Template:Cite book"},{"ns":10,"exists":"","*":"Template:PD-notice"},{"ns":10,"exists":"","*":"Template:Cite web"},{"ns":10,"exists":"","*":"Template:Cite journal"},{"ns":10,"exists":"","*":"Template:Dead link"},{"ns":10,"exists":"","*":"Template:CC-notice"},{"ns":10,"exists":"","*":"Template:Main other"},{"ns":10,"exists":"","*":"Template:Male genital procedures"},{"ns":10,"exists":"","*":"Template:Navbox"},{"ns":828,"exists":"","*":"Module:Infobox"},{"ns":828,"exists":"","*":"Module:Navbar"},{"ns":828,"exists":"","*":"Module:InfoboxImage"},{"ns":828,"exists":"","*":"Module:Unsubst"},{"ns":828,"exists":"","*":"Module:Category handler"},{"ns":828,"exists":"","*":"Module:Yesno"},{"ns":828,"exists":"","*":"Module:Category handler/data"},{"ns":828,"exists":"","*":"Module:Category handler/config"},{"ns":828,"exists":"","*":"Module:Category handler/shared"},{"ns":828,"exists":"","*":"Module:Category handler/blacklist"},{"ns":828,"exists":"","*":"Module:Namespace detect/data"},{"ns":828,"exists":"","*":"Module:Namespace detect/config"},{"ns":828,"exists":"","*":"Module:Arguments"},{"ns":828,"exists":"","*":"Module:Delink"},{"ns":828,"exists":"","*":"Module:No globals"},{"ns":828,"exists":"","*":"Module:Message box"},{"ns":828,"exists":"","*":"Module:Message box/configuration"},{"ns":828,"exists":"","*":"Module:Citation/CS1"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Configuration"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Whitelist"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Utilities"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Date validation"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Identifiers"},{"ns":828,"exists":"","*":"Module:Citation/CS1/COinS"},{"ns":828,"exists":"","*":"Module:Check for unknown parameters"},{"ns":828,"exists":"","*":"Module:Navbox"}],"images":["PD-icon.svg","Lock-green.svg","CC-BY-icon-80x15.png","PSA_KLK3_PDB_2ZCK.png","Wiki_letter_w_cropped.svg","Prostate_cancer_global_epidemiology.png"],"externallinks":["https://www.ncbi.nlm.nih.gov/books/NBK65945/","//www.ncbi.nlm.nih.gov/pubmed/26389383","https://www.cancer.gov/types/prostate/hp/prostate-screening-pdq","//doi.org/10.1002/14651858.cd004720.pub3","//www.ncbi.nlm.nih.gov/pubmed/23440794","https://emedicine.medscape.com/article/1967731-guidelines","//doi.org/10.1016/j.juro.2012.11.014","//www.ncbi.nlm.nih.gov/pubmed/23234625","//doi.org/10.3322/caac.20066","//www.ncbi.nlm.nih.gov/pubmed/20200110","http://jco.ascopubs.org/content/early/2012/07/16/JCO.2012.43.3441.full.pdf","//doi.org/10.1200/JCO.2012.43.3441","//www.ncbi.nlm.nih.gov/pmc/articles/PMC3776923","//www.ncbi.nlm.nih.gov/pubmed/22802323","//doi.org/10.1016/j.eururo.2016.08.004","//www.ncbi.nlm.nih.gov/pubmed/27543165","//doi.org/10.1016/j.eururo.2013.05.049","//www.ncbi.nlm.nih.gov/pubmed/23787356","https://www.cambridge.org/core/journals/epidemiology-and-infection/article/global-burden-of-major-infectious-complications-following-prostate-biopsy/15F4BC0A3295EFC243D0BC0CAC24CAAC","//doi.org/10.1017/S0950268815002885","//www.ncbi.nlm.nih.gov/pubmed/26645476","//www.ncbi.nlm.nih.gov/pmc/articles/PMC4216256","//doi.org/10.1503/cmaj.140703","//www.ncbi.nlm.nih.gov/pubmed/25349003","//doi.org/10.1016/j.eururo.2014.11.037","//www.ncbi.nlm.nih.gov/pubmed/25480312","//doi.org/10.1016/j.eururo.2016.07.041","//www.ncbi.nlm.nih.gov/pubmed/27568655","http://www.andrologysociety.com/resources/handbook/ch.8.asp","//doi.org/10.1016/S0022-5347(17)35233-3","//www.ncbi.nlm.nih.gov/pubmed/7512659","//www.ncbi.nlm.nih.gov/pmc/articles/PMC3709717","//doi.org/10.3390/ijms140611034","//www.ncbi.nlm.nih.gov/pubmed/23708103","//doi.org/10.1016/j.mcna.2017.11.001","//www.ncbi.nlm.nih.gov/pubmed/29406053","//doi.org/10.1001/jama.2018.3710","//doi.org/10.1053/j.seminoncol.2017.02.001","//www.ncbi.nlm.nih.gov/pubmed/28395763","//www.ncbi.nlm.nih.gov/pmc/articles/PMC2822438","//doi.org/10.1001/jama.2009.1348","//www.ncbi.nlm.nih.gov/pubmed/19755699","//doi.org/10.1200/JCO.2011.34.9738","//www.ncbi.nlm.nih.gov/pubmed/21825257","http://www.nhs.uk/Conditions/Cancer-of-the-prostate/Pages/Prevention.aspx","http://www.annfammed.org/content/16/2/149.long","//doi.org/10.1370/afm.2205","//www.ncbi.nlm.nih.gov/pmc/articles/PMC5847354","//www.ncbi.nlm.nih.gov/pubmed/29531107","//www.ncbi.nlm.nih.gov/pmc/articles/PMC4282231","//doi.org/10.14366/usg.14051","//www.ncbi.nlm.nih.gov/pubmed/25492891","//www.ncbi.nlm.nih.gov/pmc/articles/PMC4777886","//doi.org/10.4137/BECB.S34255","//www.ncbi.nlm.nih.gov/pubmed/26966397","//doi.org/10.1016/j.rcl.2017.10.013","//www.worldcat.org/issn/0033-8389","//doi.org/10.21037/tau.2017.03.77","//www.worldcat.org/issn/2223-4683","//doi.org/10.3390/diagnostics8010016","//www.ncbi.nlm.nih.gov/pubmed/29439481","http://www.mdpi.com/2075-4418/8/1/16/htm","//www.ncbi.nlm.nih.gov/pmc/articles/PMC5787224","//doi.org/10.1007/s00259-017-3882-2","//www.ncbi.nlm.nih.gov/pubmed/29282518","https://link.springer.com/article/10.1007%2Fs00259-017-3882-2","//doi.org/10.1097/CCO.0000000000000439","//www.worldcat.org/issn/1040-8746","//doi.org/10.1016/j.rcl.2017.10.008","//www.ncbi.nlm.nih.gov/pmc/articles/PMC5659858","//doi.org/10.5489/cuaj.4888","//www.ncbi.nlm.nih.gov/pubmed/29381452","//doi.org/10.1016/j.critrevonc.2017.11.007","//www.worldcat.org/issn/1040-8428","https://www.uspreventiveservicestaskforce.org/Page/Document/UpdateSummaryFinal/prostate-cancer-screening","https://screeningforprostatecancer.org/","http://mr.crossref.org/iPage?doi=10.3322/caac.20066","//www.ncbi.nlm.nih.gov/pmc/articles/PMC5341610","//doi.org/10.1038/nrurol.2016.251","//www.worldcat.org/issn/1759-4812","//www.ncbi.nlm.nih.gov/pubmed/27995937","https://web.archive.org/web/20090410034622/http://www.auanet.org/content/press/press_releases/article.cfm?articleNo=106","http://www.auanet.org/content/press/press_releases/article.cfm?articleNo=106","https://web.archive.org/web/20090326103155/http://www.auanet.org/guidelines/patient_guides/pc08.pdf","http://www.auanet.org/guidelines/patient_guides/pc08.pdf","//doi.org/10.1590/1806-9282.63.08.722","//www.worldcat.org/issn/0104-4230","//www.ncbi.nlm.nih.gov/pubmed/28977112","//doi.org/10.3322/caac.21166","//www.ncbi.nlm.nih.gov/pubmed/23335087","//www.ncbi.nlm.nih.gov/pmc/articles/PMC5811879","//doi.org/10.3909/riu0772","//www.ncbi.nlm.nih.gov/pubmed/29472826","//doi.org/10.1001/jama.2009.1498","//www.ncbi.nlm.nih.gov/pubmed/19843904","//doi.org/10.1200/JCO.2010.32.5308","//www.ncbi.nlm.nih.gov/pubmed/21189396","//doi.org/10.1001/jama.276.24.1976","//www.ncbi.nlm.nih.gov/pubmed/8971068","https://books.google.com/books?id=UlOUF4MpQ-8C","http://www.mayoclinic.com/health/prostate-cancer/HQ01273","//doi.org/10.2217/bmm.11.53","//www.ncbi.nlm.nih.gov/pubmed/21861672","//doi.org/10.1056/NEJMoa0810084","//www.ncbi.nlm.nih.gov/pubmed/19297566","//doi.org/10.1016/j.ejca.2009.09.008","//www.ncbi.nlm.nih.gov/pubmed/19804966","https://web.archive.org/web/20071028005357/http://www.epi.bris.ac.uk/protect/","http://www.epi.bris.ac.uk/protect","http://www.controlled-trials.com/ISRCTN92187251","http://www.controlled-trials.com/ISRCTN20141297","http://www.bristol.ac.uk/population-health-sciences/projects/protect/about/"],"sections":[{"toclevel":1,"level":"2","line":"Prostate-specific antigen","number":"1","index":"1","fromtitle":"Prostate_cancer_screening","byteoffset":7529,"anchor":"Prostate-specific_antigen"},{"toclevel":1,"level":"2","line":"Digital rectal examination","number":"2","index":"2","fromtitle":"Prostate_cancer_screening","byteoffset":12761,"anchor":"Digital_rectal_examination"},{"toclevel":1,"level":"2","line":"Follow up tests","number":"3","index":"3","fromtitle":"Prostate_cancer_screening","byteoffset":13906,"anchor":"Follow_up_tests"},{"toclevel":2,"level":"3","line":"Biopsy","number":"3.1","index":"4","fromtitle":"Prostate_cancer_screening","byteoffset":13929,"anchor":"Biopsy"},{"toclevel":2,"level":"3","line":"Ultrasound","number":"3.2","index":"5","fromtitle":"Prostate_cancer_screening","byteoffset":14347,"anchor":"Ultrasound"},{"toclevel":2,"level":"3","line":"Magnetic imaging","number":"3.3","index":"6","fromtitle":"Prostate_cancer_screening","byteoffset":15182,"anchor":"Magnetic_imaging"},{"toclevel":2,"level":"3","line":"Other imaging","number":"3.4","index":"7","fromtitle":"Prostate_cancer_screening","byteoffset":16830,"anchor":"Other_imaging"},{"toclevel":2,"level":"3","line":"Other","number":"3.5","index":"8","fromtitle":"Prostate_cancer_screening","byteoffset":19587,"anchor":"Other"},{"toclevel":1,"level":"2","line":"Guidelines","number":"4","index":"9","fromtitle":"Prostate_cancer_screening","byteoffset":20883,"anchor":"Guidelines"},{"toclevel":1,"level":"2","line":"Controversy","number":"5","index":"10","fromtitle":"Prostate_cancer_screening","byteoffset":27045,"anchor":"Controversy"},{"toclevel":1,"level":"2","line":"History","number":"6","index":"11","fromtitle":"Prostate_cancer_screening","byteoffset":33459,"anchor":"History"},{"toclevel":1,"level":"2","line":"See also","number":"7","index":"12","fromtitle":"Prostate_cancer_screening","byteoffset":37376,"anchor":"See_also"},{"toclevel":1,"level":"2","line":"References","number":"8","index":"13","fromtitle":"Prostate_cancer_screening","byteoffset":37509,"anchor":"References"}],"parsewarnings":[],"displaytitle":"Prostate cancer screening","iwlinks":[{"prefix":"creativecommons","url":"https://creativecommons.org/licenses/by/4.0/","*":"creativecommons:by/4.0/"}],"properties":[{"name":"wikibase_item","*":"Q7250979"}]}}